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ABSTRACT 
 
Glomerular epithelial cells, podocytes, and the specialized cell junctions termed slit 
diaphragms (SDs) between interdigitating foot processes of the podocytes form the 
essential components of the filtration barrier in the kidney glomerulus. Nephrin is a 
transmembrane immunoglobulin superfamily member and a crucial structural and 
signalling component of the SD. Mutations in the nephrin gene cause congenital nephrotic 
syndrome of the Finnish type (CNF), leading to disruption of the SD and leakage of plasma 
proteins into the urine. The Neph-protein family comprises Neph1, Neph2 and Neph3; 
these are nephrin homologues and also important components of the SD. Interactions 
between nephrin and Neph1-3 are suggested to play a role in cell adhesion and thus serve as 
a structural framework of the SD. This thesis investigated the interactions and cell adhesion 
activities of nephrin and Neph-family members and specifically focused on examining 
whether Neph3 has similar functions as nephrin, Neph1 and Neph2. Neph3 was shown to 
belong to the nephrin protein complex and to form homodimers, indicating that Neph3 
shares similar binding properties with nephrin, Neph1 and Neph2. Both Neph1 and Neph3 
were demonstrated to participate in the formation of cell-cell contacts by their homophilic 
interactions. Cell adhesion was also promoted by heterophilic trans-interactions between 
nephrin and Neph1 or Neph3. These adhesive activities may play an important role in the 
formation and function of the SD. In nephrin-deficient mice, where SDs are replaced by 
tight junction-like structures, Neph3 was shown to be up-regulated. This suggests that 
Neph3 may be involved in molecular mechanisms that are associated with morphological 
changes in injured podocytes. 
Nephrin and Neph3 genes, NPHS1 and KIRREL2, respectively, are located on human 
chromosome 19q13.12 in a head-to-head orientation separated by an approximately 5-kb 
intergenic region. A similar bidirectional arrangement of nephrin and Neph3 genes is 
present in mouse and rat chromosomes. The bidirectional and conserved arrangement of 
nephrin and Neph3 genes together with their similar protein structure and location suggest 
that nephrin and Neph3 genes may share key features in their regulation. This work focused 
on investigating transcriptional regulatory mechanisms and factors important for nephrin 
and Neph3 genes. Transcription factors WT1 and NF-?B were shown to function co-
operatively in both nephrin and Neph3 gene regulation. Further, DNA methylation 
participated in silencing both nephrin and Neph3 gene expression. These similar 
mechanisms in regulating transcription of nephrin and Neph3 genes may produce their 
similar spatial and temporal expression as well as similar function. In addition, transcription 
factors GABP and Sp1 were found to regulate nephrin and Neph3 genes, respectively. 
The results of this thesis widen the current understanding of the role of nephrin and Neph-
family members in the formation of the SD by showing that Neph3 belongs to the nephrin 
protein complex and that interactions of nephrin, Neph1 and Neph3 promote cell adhesion. 
Further, nephrin and Neph3 genes were demonstrated to share similar transcriptional 
regulatory mechanisms. This may improve understanding of the transcriptional regulation 
of podocytes in general. 
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1 REVIEW OF THE LITERATURE 
1.1 Kidney – anatomy and function 
Kidneys are paired bean-shaped organs located in the posterior abdominal cavity on each 
side of the vertebral column that are vital in maintaining normal body functions. They filter 
plasma to secrete metabolic waste products from the bloodstream into the urine and 
participate in the regulation of acid-base, electrolyte and fluid balance of the body. Kidneys 
also secrete hormones that regulate blood pressure and red blood cell formation. The 
functional unit of the kidney is a nephron, and each human kidney contains approximately 
one million nephrons. The nephron consists of the glomerulus, which is a capillary tuft 
surrounded by Bowman’s capsule, and the tubular system comprising the proximal tubule, 
the loop of Henle and the distal tubule. Glomeruli form about 180 l of primary urine daily 
that is modified in the tubular system by effective reabsorption of valuable substances, such 
as  water,  electrolytes,  glucose  and  amino  acids,  into  the  circulation  (Tisher  and  Madsen,  
1991). 
1.2 Glomerular filtration barrier 
The ultrafiltration of plasma in the glomerulus (Figure 1A) occurs through the glomerular 
filtration barrier (Figure 1B) between the capillary lumen and the urinary space. The barrier 
consists of three layers and filtration occurs in a size-, charge- and shape-selective manner. 
The fenestrated endothelium on the capillary loop side represents the initial barrier and 
lines the middle layer, the glomerular basement membrane (GBM). Highly differentiated 
glomerular epithelial cells, podocytes, in the urinary space form the final filter by their cell-
cell contacts called slit diaphragms (SDs). In addition to these three layers, the 
intraglomerular mesangium located among the glomerular capillaries contributes to the 
regulation of ultrafiltration (reviewed by Haraldsson et al., 2008). 
1.2.1 Podocytes and the slit diaphragm (SD) 
Podocytes are polarized, highly differentiated epithelial cells with a unique architecture 
comprising a cell body and long, extending primary processes that divide further into 
thinner, numerous secondary foot processes. The podocyte cell body lies in the urinary 
space facing Bowman’s capsule, while the foot processes line the outside of the glomerular 
capillaries.  The  basal  side  of  the  foot  processes  is  anchored  to  the  GBM  via  adhesion  
molecules, including ?3?1-integrin and ?- and ?-dystroglycan (Figure 2) (Korhonen et al., 
1990; Adler, 1992; Raats et al., 2000; Regele et al., 2000). The apical side of the podocyte 
foot processes faces the urinary space and possesses the heavily sialylated glycoprotein 
podocalyxin as one the main molecular components, giving a negative charge to the apical 
membrane (Figure 2) (Kerjaschki et al., 1984). The foot processes attached to the GBM are 
arranged in a highly organized manner so that the foot processes from adjacent podocytes 
11 
 
interdigitate and are separated by about a 40-nm-wide slit. A specialized cell junction 
termed slit diaphragm (SD), located between the basal and apical side of the podocyte foot 
processes, connects the interdigitating foot processes to each other (Figure 2) (Rodewald 
and Karnovsky, 1974). Based on electron microscopic examination, the SD has been 
described as a zipper-like structure with pores whose dimensions are almost the same as the 
size of albumin (70 kDa) (Rodewald and Karnovsky, 1974). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. (A) Schematic structure of the glomerulus. Modified from Kriz et al. (1998). (B) 
Schematic representation of the glomerular filtration barrier. GBM, glomerular basement 
membrane. 
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Figure 2. Simplified presentation of the molecular composition of the podocyte foot 
processes and the SD, indicating key proteins and protein families. Modified from Cohen et 
al. (2006). SD, slit diaphragm; GBM, glomerular basement membrane.  
 
1.2.1.1 Composition and functions of the SD 
The SD is a protein complex representing adhesion and signalling functions (Figure 2). The 
complex includes proteins that are common for most cell junctions, but also proteins that 
are not found in other junctions. Transmembrane proteins nephrin and Neph-protein family 
(Neph1-3) are suggested to form the framework of the SD (Section 1.3) (Ruotsalainen et 
al., 1999; Barletta et al., 2003; Gerke et al., 2003; Khoshnoodi et al., 2003; Liu et al., 2003; 
Wartiovaara et al., 2004; Gerke et al., 2005). In addition, the SD contains several 
scaffolding proteins often associated with tight junctions such as ZO-1 (Zonula occludens-
1) (Schnabel et al., 1990), MAGI-1 (membrane-associated guanylate kinase inverted-1) 
(Hirabayashi et al., 2005), MAGI-2 (Lehtonen et al., 2005) and CASK (calmodulin-
associated serine/threonine kinase) (Lehtonen et al., 2004). Proteins present in adherens 
junctions, including catenins (Reiser et al., 2000; Lehtonen et al., 2004) and cadherin 
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superfamily proteins P-cadherin (Reiser et al., 2000), VE-cadherin (Cohen et al., 2006) and 
FAT1 (Inoue et al., 2001) as well as tight junction proteins JAM-A (junctional adhesion 
molecule A), occludin and cingulin (Fukasawa et al., 2009), are also present in the SD. 
Based on its composition, the SD is considered a specialized adherens junction which 
harbours characteristics of both adherens and tight junctions (Schnabel et al., 1990; Reiser 
et al., 2000). Adherens junctions mediate cell-cell adhesion, whereas tight junctions help to 
maintain the polarity of cells and provide a cellular barrier for the passage of water, 
molecules and ions. Similarly, the SD functions as a bridge between neighbouring 
podocytes, polarizes podocytes, and also has a structural function as a molecular sieve. 
The SD also represents a signalling platform that contributes to, for instance, the regulation 
of cytoskeletal organization, cell polarity and cell survival of podocytes (reviewed by 
Benzing, 2004). These signalling pathways are influenced by the action of certain SD 
proteins. Phosphorylation of nephrin and Neph1 is known to activate signalling pathways in 
podocytes (see Sections 1.3.1.2 and 1.3.2). Another SD protein, podocin, contributes to the 
intracellular signalling cascade by interacting with nephrin (Boute et al., 2000; Huber et al., 
2003c; Li et al., 2004). An adaptor protein CD2AP (CD2-associated protein) in the 
podocyte cytoplasm is linked to activation of PI3K (phosphoinositide 3-kinase) and 
stimulation of a serine/threonine kinase AKT-dependent signalling (Li et al., 2000; Huber 
et  al.,  2003a).  CD2AP,  as  well  as  ZO-1,  functions  also  in  linking  the  SD  to  the  actin  
cytoskeleton (Fanning et al., 2002; Lehtonen et al., 2002; Huber et al., 2003b), and adaptor 
proteins Nck1 (non-catalytic region of tyrosine kinase adaptor protein 1) and Nck2 have an 
important function affecting the regulation of actin assembly in podocytes (Jones et al., 
2006; Verma et al., 2006; Blasutig et al., 2008). Furthermore, cell polarity complex 
composed of Par3, Par6 and aPKC (atypical protein kinase C) has been located at the 
cytoplasmic side of the SD and shown to play a role in podocyte polarization and correct 
positioning of the SD (Hartleben et al., 2008; Hirose et al., 2009; Huber et al., 2009). 
1.2.1.2 Podocyte cytoskeleton 
The unique morphology of podocytes is influenced by a complex cytoskeleton. 
Microtubules and intermediate filaments dominate in the cell body and primary processes. 
Foot process architecture, in turn, is supported by a network of actin filaments cross-linked 
by ?-actinin-4 (Figure 2) (reviewed by Pavenstadt et al., 2003). ?-actinin-4 gene is mutated 
in a kidney disease called familial focal segmental glomerulosclerosis characterized by 
podocyte foot process effacement and proteinuria, emphasizing the role of the actin 
cytoskeleton in maintaining functional foot process architecture (Kaplan et al., 2000). The 
foot process cytoskeleton is linked by several adapter proteins to all three podocyte plasma 
membrane domains, the basal, lateral (SD) and apical domains, and is therefore responsible 
for, for instance, keeping podocytes attached to the GBM. The cytoskeleton also serves as a 
platform for transmitting signals from the extracellular environment and neighbouring 
podocytes, and provides mechanical stability and a high dynamic capacity to respond to 
physical stress (reviewed by Pavenstadt et al., 2003).  
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1.2.1.3 Nephrogenesis and development of podocytes and the SD 
Mammalian kidney development contains three kidney structures: pronephros, 
mesonephros and metanephros. The development of metanephros, the permanent kidney, is 
a process that involves reciprocal interactions between the ureteric bud (UB) and the 
metanephric mesenchyme (MM). These interactions induce a series of events starting with 
the condensation of MM cells at the tips of the UB. The aggregated cells then begin to 
undergo mesenchyme-to-epithelial conversion and form renal vesicles. Renal vesicle stage 
is followed by comma-shaped and S-shaped stages. The S-shaped body fuses with the UB-
derived collecting duct to form a capillary loop stage glomerulus that differentiates into a 
mature glomerulus (reviewed by Horster et al., 1997). 
Podocyte precursors appear first at the S-shape body stage and are recognized by the 
expression of podocyte-specific markers such as transcription factor WT1 (Wilms’ tumour 
1) (Mundlos et al., 1993) and transmembrane proteins Glepp1 (Sharif et al., 1998) and 
nephrin (Ruotsalainen et al., 2000). At this stage, the developing podocytes are columnar 
epithelial cells that are connected by apical junctional complexes composed of typical tight 
and adherens junction proteins (Schnabel et al., 1990). As podocytes differentiate, junctions 
migrate down the cell membrane towards the basal side of podocytes during the capillary 
loop stage, and the formation and interdigitation of the podocyte foot processes begins. 
During interdigitation podocyte cell bodies become independent of each other, but 
podocytes remain connected by tight junctions between the interdigitated foot processes 
(Figure 3). Tight junctions are replaced by the SDs in mature glomeruli (Reeves et al., 
1978). 
 
 
 
Figure 3. Schematic illustration of podocyte development from an S-shaped body stage to a 
mature glomerulus with respect to the junction translocation and foot process formation. 
 
1.2.2 Glomerular basement membrane 
The glomerular basement membrane (GBM) separates endothelial cells and podocytes. 
GBM is a tight, highly cross-linked meshwork of laminin, type IV collagen and nidogen. 
Heparan sulphate proteoglycans (HSPGs) bind to collagen and laminin, providing anionic 
charge to the GBM due to their negatively charged glycosaminoglycan side-chains. This 
has long been considered to be an important contributor to the charge-selectivity of the 
filtration barrier (reviewed by Haraldsson et al., 2008). 
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1.2.3 Endothelial cells 
Glomerular endothelial cells line the interior surface of the glomerular capillaries and the 
luminal side of the GBM. The glomerular endothelium has numerous round or ovoid 
transcellular holes, fenestrations (70-100 nm in diameter in humans), that allow the passage 
of fluid across the cell layer. The luminal side of the endothelial cells and the fenestrae are 
covered by an endothelial cell surface layer consisting of a glycocalyx and an endothelial 
cell coat. The components of the endothelial cell surface layer, glycoproteins, 
glycosaminoglycans and proteoglycans, give a negative charge to the endothelial cells and 
are hypothesized to contribute to the charge-selective properties of the glomerular filtration 
barrier (reviewed by Haraldsson et al., 2008). 
1.2.4 Mesangium 
The mesangial cells and their surrounding matrix material constitute the mesangium, which 
is located between the capillary loops of the glomerular tuft. The main functions of the 
mesangium are to provide structural support for the glomerular capillaries and to participate 
in the regulation of glomerular filtration. Mesangial cells resemble smooth muscle cells 
having contractile properties. Cell contraction is stimulated by a variety of vasoactive 
agents. Mesangial cells also have phagocytic activity and thus may contribute to the 
clearance of debris from the filtration barrier (reviewed by Stockand and Sansom, 1998). 
1.2.5 Glomerular filtration 
High blood pressure within the glomerulus forces ultrafiltration of plasma through the 
filtration barrier. The selective function of the filtration barrier almost completely restricts 
the  passage  of  albumin  and  larger  plasma  proteins  as  well  as  blood  cells  into  the  urine,  
while some proteins of smaller molecular size pass the filtration barrier freely. This is not, 
however, a problem since the majority of these proteins are returned back to the circulation 
by active reabsorption in the tubular system. Dysfunction of the glomerular filtration barrier 
leads to leakage of proteins that are normally kept in the circulation across the filtration 
barrier.  This  overloads  the  tubular  reabsorption  capacity  and  proteins  pass  into  the  
collecting duct and subsequently into urine. This condition is called proteinuria and can be 
caused by several factors such as autoimmune diseases, local inflammation, toxic effects, 
metabolic products and genetic mutations (reviewed by Nielsen and Christensen, 2010). 
It is generally accepted that filtration across the glomerular filtration barrier restricts the 
passage of solutes depending on their size, charge and shape. There have long been 
speculations about which of the three layers of the glomerular filtration barrier – endothelial 
cells, glomerular basement membrane or podocyte slit diaphragm – restricts the passage of 
proteins the most. However, it is now becoming increasingly apparent that the filtration 
barrier should be seen as a single unit where each layer makes a significant contribution to 
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the selective permeability. Each layer provides resistance to the movement of water and 
solutes across the barrier in a manner predicted by biophysical models. In addition, the 
structure and composition of each layer of the barrier bear a consequence for adjacent 
layers of the barrier through biophysical interactions affecting the manner and rate at which 
solutes and solvent enter and/or exit adjacent layers of the barrier (reviewed by Haraldsson 
et al., 2008). 
1.3 Nephrin and Neph-protein family 
Nephrin and the members of the Neph-protein family, Neph1, Neph2 and Neph3, are 
homologous  molecules  and crucial  components  of  the  SD.  They are  assumed to  play  key 
roles in cell-cell adhesion through their interactions, thus serving as a structural framework 
of  the  SD.  Nephrin  and  Neph-family  members  also  impact  the  signalling  events  in  
podocytes. 
1.3.1 Nephrin 
The nephrin gene NPHS1 was identified in 1998 (Kestilä et al., 1998) and later the protein 
was localized to the SD (Holthöfer et al., 1999; Holzman et al., 1999; Ruotsalainen et al., 
1999). The human nephrin gene NPHS1 has 29 exons spanning a 26-kb area on 
chromosome 19q13.12 (Kestilä et al., 1998). NPHS1 is mutated in the congenital nephrotic 
syndrome of the Finnish type (CNF), a serious renal disease described already in 1956 
(Hallman et al., 1956; Kestilä et al., 1998). In mice, inactivation of the nephrin gene leads 
to morphological alterations, resembling findings in CNF patients (Putaala et al., 2001; 
Rantanen et al., 2002), further demonstrating the importance of nephrin in the SD structure 
and function. 
1.3.1.1 Congenital nephrotic syndrome of the Finnish type (CNF) 
Congenital nephrotic syndrome of the Finnish type (CNF), an autosomal recessively 
inherited disease, occurs worldwide but is highly concentrated in the Finnish population. 
The incidence of CNF in Finland is approximately one in 8000 live births (Hallman et al., 
1956; Norio, 1966). CNF is characterized by heavy proteinuria already in utero, oedema, 
premature birth and large placenta (Hallman et al., 1973; Huttunen et al., 1976). 
Macroscopically, the kidneys of CNF patients are 2-3 times larger than the kidneys of 
normal children, and microscopic findings include increased glomerular size and number 
(Tryggvason and Kouvalainen, 1975; Tryggvason, 1978; Autio-Harmainen and Rapola, 
1981). The most characteristic microscopic finding is effacement and fusion of podocyte 
foot processes. The number of the slits between podocytes is decreased, the width of the 
slits varies greatly and the typical zipper-like structure of the SD is lacking (Patrakka et al., 
2000; Ruotsalainen et al., 2000; Lahdenkari et al., 2004). Historically, CNF patients have 
had a poor prognosis, with most of them dying during the neonatal period. During the last 
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25 years the only life-saving treatment has been dialysis and intravenous nutrition, followed 
by kidney transplantation in early childhood (reviewed by Holmberg et al., 1995). 
CNF is caused by mutations in NPHS1, and, to date, over 100 mutations in NPHS1 have 
been reported worldwide (www.biobase-international.com), most of them leading to 
deficiency of nephrin protein and severe disease. There are two main mutations among the 
Finnish population, Finmajor and  Finminor, accounting for over 90% of the cases. Both 
mutations lead to a truncated nephrin protein; Finmajor is a two base pair frameshift deletion 
in exon 2, resulting in an early stop codon, and Finminor is a nonsense mutation in exon 26 
(Kestilä et al., 1998). In contrast to the Finnish CNF patients, most non-Finnish patients 
have individual mutations. These include deletions and insertions and nonsense, missense 
and splicing mutations that are scattered along the whole gene (Lenkkeri et al., 1999; 
Beltcheva et al., 2001). In addition to mutations in the coding region of NPHS1, mutations 
in the regulatory region of the nephrin gene have been identified. Deletions of multiple 
nucleotides in a GA repeat region in the nephrin proximal promoter have been observed in 
several patients (Lenkkeri et al., 1999). Further, G to C substitution in the nephrin proximal 
promoter has been described in two independent studies (Gigante et al., 2002; Koziell et al., 
2002). 
1.3.1.2 Structure and functions of nephrin protein 
Nephrin is a transmembrane protein and belongs to the immunoglobulin (Ig) superfamily. It 
has a short C-terminal intracellular domain, a single-span transmembrane region and an 
extracellular domain with eight Ig-like motifs and one fibronectin type III domain (Figure 
4) (Kestilä et al., 1998). The Ig-like motifs are type C2, which is characteristic for proteins 
participating in cell-cell or cell-matrix interactions (reviewed by Chothia and Jones, 1997). 
Based on the structure of nephrin and its localization to the podocyte SD, nephrin 
molecules have been proposed to form a zipper-like structure, where extracellular domains 
of nephrin extend from neighbouring podocyte foot processes and interact with each other 
via  the  Ig-like  domains  in  the  centre  of  the  SD  (Ruotsalainen  et  al.,  1999;  Gerke  et  al.,  
2003; Khoshnoodi et al., 2003; Wartiovaara et al., 2004). 
 
 
 
 
 
 
 
 
 
 
Figure 4. Domain structure of nephrin. Ig, immunoglobulin. 
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Besides being a structural component of the SD, nephrin also has signalling functions. This 
is enabled by the association of nephrin with specific microdomains of the cell membrane 
called lipid rafts (Simons et al., 2001) and the presence of tyrosine residues in the nephrin 
intracellular domain serving as a target for phosphorylation (Verma et al., 2003). Fyn, a 
member of the Src family kinases, has been shown to directly bind to the intracellular 
domain of nephrin and mediate nephrin phosphorylation (Lahdenperä et al., 2003; Verma et 
al., 2003). Fyn and nephrin phosphorylation seem to be important for the maintenance of 
the SD, as Fyn-deficient mice have foot process effacement and proteinuria (Yu et al., 
2001; Verma et al., 2003). Tyrosine-phosphorylated nephrin creates docking sites for many 
proteins, and these interactions lead to a stimulation of various signalling events. For 
example, binding of p85, a regulatory subunit of PI3K, to the phosphorylated nephrin 
activates AKT and further inhibits podocyte apoptosis by regulating apoptosis-associated 
molecules (Huber et al., 2003a). Nephrin interaction with another SD protein podocin, 
leading to augmented nephrin-mediated signalling, is also enhanced by nephrin 
phosphorylation (Huber et al., 2001; Li et al., 2004). Nephrin phosphorylation is further 
linked to the pathways that lead to an elevation in cytosolic calcium levels (Harita et al., 
2009) and raft-mediated endocytosis of nephrin (Qin et al., 2009). Association of Nck 
adaptor proteins with phosphorylated nephrin and cytoskeletal regulator proteins leads to 
actin cytoskeleton regulation (Jones et al., 2006; Verma et al., 2006). This seems to be 
important for foot process formation since deletion of Nck1/Nck2 in developing and adult 
podocytes in mice results in podocyte foot process effacement (Jones et al., 2006; Jones et 
al., 2009). Nephrin is suggested to participate in organizing the podocyte actin cytoskeleton 
also by interacting with actin-associating and actin-modifying proteins like CD2AP, CASK, 
IQGAP1 and ?-actinin-4 (Lehtonen et al., 2002; Palmen et al., 2002; Lehtonen et al., 2004; 
Lehtonen et al., 2005). 
1.3.1.3 Nephrin expression and its splicing variants 
In the human kidney, nephrin is expressed only in the podocytes where it localizes at the 
SD (Kestilä et al., 1998; Ruotsalainen et al., 1999). Extensive studies of human and porcine 
foetal, newborn and infant tissues did not show nephrin expression outside the kidney 
(Kuusniemi et al., 2004), but other studies have reported nephrin expression in adult human 
pancreas  and  lymphoid  tissue  (Palmen  et  al.,  2001;  Zanone  et  al.,  2005;  Åström  et  al.,  
2006). In mice and rats, nephrin is expressed, in addition to podocytes (Kawachi et al., 
2000; Putaala et al., 2000), also in the central nervous system (Putaala et al., 2000; Li et al., 
2011), and in mice also in the pancreas, spleen, thymus and testis (Putaala et al., 2000; Liu 
et al., 2001). In addition to the full-length sequence, different splice variants of nephrin 
have been indentified; one in humans and four in rats. The human splice variant lacks the 
whole transmemebrane domain encoded by exon 24, and the rat splice variants lack entirely 
or partly exons 24-27 (Ahola et al., 1999; Holthöfer et al., 1999). These splicing variants 
appear to have distinct tissue specificity. Mouse nephrin has an alternative transcription 
start site (TSS) located 1808 bp upstream from the previously detected first exon, and its 
expression is detected only in the central nervous system (Beltcheva et al., 2003). Further, 
in the mouse, the endogenous antisense mRNA of nephrin is expressed in the brain, 
lymphoid tissue and embryonic stem cells (Ihalmo et al., 2004). 
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1.3.2 Neph-protein family 
The first Neph-family member Neph1 was identified in 2001 (Donoviel et al., 2001) and 
led to the establishment of the Neph-protein family when two other closely related proteins, 
Neph2 and Neph3, were identified two years later (Ihalmo et al., 2003; Sellin et al., 2003). 
Members of the Neph-protein family, similarly to nephrin, belong to the Ig superfamily and 
are transmembrane proteins composed of a short intracellular domain, a single-span 
transmembrane region and an extracellular domain with five Ig-like motifs (Figure 5) 
(Ihalmo  et  al.,  2003;  Sellin  et  al.,  2003).  Further,  they  all  localize  to  the  podocyte  SD  
(Barletta et al., 2003; Liu et al., 2003; Gerke et al., 2005; Ihalmo et al., 2007). The 
phenotype of mice lacking Neph1 resembles that of nephrin-deficient mice, and these mice 
exhibit podocyte foot process effacement, develop proteinuria and die during the early 
postnatal period (Donoviel et al., 2001). Mice lacking Neph2- or Neph3 have not been 
created thus far. However, disruption of the functions of Neph2 and Neph3 has been 
achieved in zebrafish, whose pronephros is composed of the same cell types as found in the 
higher vertebrate kidney, including podocytes and SDs (Drummond et al., 1998). 
Disruption of Neph2 expression in zebrafish results in podocyte foot process effacement, 
lack of SDs and leaking of the glomerular filtration barrier (Neumann-Haefelin et al., 
2010). A similar phenotype was noted when Neph1 expression was disrupted (Neumann-
Haefelin et al., 2010). Disruption of Neph3 expression in zebrafish led to a distorted body 
curvature, transient pericardial oedema and altered pronephros morphology, suggesting that 
Neph3 is involved in the regulation of glomerular development (Wang et al., 2012). 
 
 
 
 
 
 
 
 
Figure 5. Domain structure of Neph1-3. Ig, immunoglobulin. 
 
 
 
The members of the Neph-protein family are suggested to share many functional 
similarities with nephrin. Neph1 localizes to lipid rafts (Barletta et al., 2003), and therefore, 
similarly to nephrin, it may function as a signalling protein. All three Neph-family members 
have potential tyrosine phosphorylation sites, and highly conserved Grb2 (growth factor 
receptor-bound protein 2) and PDZ (PSD-95/disc large/ZO-1) -binding motifs in their 
intracellular domains (Sellin et al., 2003). Neph1 is tyrosine-phosphorylated by Fyn, 
enabling the interaction of Grb2 with Neph1 and leading to actin polymerization (Sellin et 
al., 2003; Garg et al., 2007). Phosphorylation of the Grb2 binding motif in Neph1 also 
regulates the interaction between Neph1 and podocin (Sellin et al., 2003). Moreover, the 
association of Neph1 with ZO-1 is mediated by the PDZ-binding motif and increases 
tyrosine phosphorylation of Neph1, further inducing signal transduction (Huber et al., 
2003b). 
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Neph1 and Neph2 form homodimers and the extracellular domains of Neph1 and Neph2 
have been shown to interact with nephrin. These interactions are mediated by the Ig-like 
motifs present in their extracellular domains (Barletta et al., 2003; Gerke et al., 2003; Liu et 
al., 2003; Gerke et al., 2005). Disruption of the nephrin-Neph1 interaction in vivo by 
injecting combinations of nephrin and Neph1 antibodies into the rat has proven the 
importance of the nephrin-Neph1 interaction. Injection results in proteinuria, but the 
podocyte foot processes are preserved. However, the expression of the intracellular binding 
partner of nephrin and Neph1, ZO-1, is dramatically reduced in antibody-injected animals 
(Liu et al., 2003). The interactions between Neph-family members and nephrin are 
proposed to play a role in the cell-cell adhesion in the SD and also to have an impact on the 
intracellular signal transduction machinery. 
Interestingly, KIRREL2, the gene encoding Neph3, locates in close proximity to the nephrin 
gene NPHS1 on human chromosome locus 19q13.12. The genes are arranged in a head-to-
head orientation and separated by an approximately 5-kb intergenic region (Ihalmo et al., 
2003). In mouse 7qB1 and rat 1q21chromosomes, nephrin and Neph3 genes also have a 
bidirectional arrangement, but the genes are separated by about a 3-kb region. This 
arrangement implies that nephrin and Neph3 genes may share similar mechanisms in 
transcriptional regulation. Neph3 mRNA expression is down-regulated in human 
proteinuric diseases, and its expression level shows a positive correlation with nephrin 
mRNA in patients with diabetic nephropathy, suggesting common regulatory mechanisms 
controlling nephrin and Neph3 gene expression (Ihalmo et al., 2007). In the kidney, besides 
the podocyte SD, Neph3 expression has been detected in proximal and distal tubuli (Ihalmo 
et al., 2003). Outside the kidney, Neph3 is expressed in the human brain, pancreas and 
lymph nodes and also in the mouse central nervous system (Sun et al., 2003; Minaki et al., 
2005; Rinta-Valkama et al., 2006). Different splicing variants with distinct tissue specificity 
have been suggested for Neph3. These represent forms of Neph3 that lack exon 2 or exon 4 
or consist only of the sequence coding for the N-terminal extracellular part fused to the C-
terminal intracellular part (Ihalmo et al., 2003, Sun et al., 2003). 
1.3.3 Orthologues of nephrin and Neph-family members in Drosophila and 
Caenorhabditis elegans 
Nephrin and Neph-family members are evolutionarily conserved, and a cell-cell recognition 
module composed of these proteins is also highly conserved across species (Neumann-
Haefelin et al., 2010). In Drosophila, two nephrin orthologues, Hibris and Sticks-and-
stones (Sns), and two orthologues of Neph-family members, irreC/Roughest (Rst) and Kin 
of irre (Kirre/Dumbfounded) have been identified (Bour et al., 2000; Ruiz-Gomez et al., 
2000; Dworak et al., 2001; Strunkelnberg et al., 2001). In C. elegans, the nephrin 
orthologue is SYG-2 and the orthologue of Neph-family members is SYG-1 (Shen and 
Bargmann, 2003; Shen et al., 2004). These proteins share similar functions in processes 
such as development of muscle and eye in Drosophila (Dworak et al., 2001; Bao and 
Cagan, 2005) and synapse development in C. elegans (Shen et al., 2004). The proteins are 
expressed in different cell types and promote junction formation and/or localization through 
their interactions. 
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During muscle development in Drosophila, heterophilic interaction between Hibris and Kin 
of irre mediates adhesion and fusion between myoblasts (Dworak et al., 2001). In pupal eye 
development, heterophilic interaction of Hibris and Rst promotes cell adhesion, which is 
required for proper patterning of the eye unit (Bao and Cagan, 2005; Carthew, 2007). In C. 
elegans, SYG-1 and SYG-2 are involved in synapse formation via their heterophilic 
interaction in trans (Shen and Bargmann, 2003; Shen et al., 2004; Wanner et al., 2011). 
Studies in C. elegans also show that all mammalian Neph-family members are able to drive 
synapse formation, suggesting a functional overlap between these three homologues 
(Neumann-Haefelin et al., 2010). Further, a highly conserved intracellular PDZ-binding 
motif of SYG-1, similarly to a PDZ-binding motif of mammalian Neph1-3, is suggested to 
be essential for its signalling functions and subsequent morphogenetic events (Neumann-
Haefelin et al., 2010; Wanner et al., 2011). 
Drosophila and C. elegans lack a glomerular filtration structure comparable with SD. 
However, studies investigating functions of nephrin and Neph-family members in these 
model organisms, even though in different settings, may contribute to the functional 
understanding of nephrin and Neph-family members in the SD. 
1.4 Transcriptional regulation in podocytes 
1.4.1 General aspects of transcriptional regulation 
Transcriptional regulation is one of the steps in the regulation of gene expression. Gene 
expression covers the entire process from transcription to the synthesis of a protein that 
carries out the function specified by the gene. The regulation of gene expression can take 
place at any point in this pathway and the purpose of the regulation is to assure spatial and 
temporal expression of proteins enabling cells to respond to changing conditions and to 
undergo normal cell growth, development and differentiation. Specifically, regulation can 
occur at the levels of transcription and chromatin structure, which are responsible for 
producing precursor mRNA (pre-mRNA). Regulation at the post-transcriptional level 
includes conversion of pre-mRNA into mature mRNA by 5’ and 3’ processing and splicing, 
control of mRNA transport from nucleus into cytoplasm and stabilization or degradation of 
mRNA. Translational mechanisms control the production of protein from mRNA by 
ribosomes, and protein stabilizations and modifications such as glycosylation, 
phosphorylation, acetylation, methylation and disulphide bond formation constitute the 
post-translational levels of gene expression regulation (reviewed by Orphanides and 
Reinberg, 2002). 
Transcription can be divided into four discrete stages: initiation, promoter clearance, 
elongation and termination. Although biologically significant regulation may occur at any 
stage in the process, most of the control is achieved by regulating the transcription 
initiation. Transcription initiation is thought to occur via binding of specific transcription 
factors to the regulatory elements in promoter regions of a given gene. This recruits the 
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general transcription factors and the RNA polymerase II (Pol II) to the core promoter, and 
Pol  II  can  initiate  the  synthesis  of  mRNA. Afterwards,  Pol  II  progresses  to  elongation  to  
produce the nascent transcript by RNA Pol II elongation factors. 
1.4.1.1 Transcription initiation complex 
General transcription factors and RNA polymerase II 
RNA polymerase II (Pol II) is responsible for all protein-encoding gene synthesis in 
eukaryotes. Pol II is capable of unwinding DNA, synthesizing RNA and rewinding DNA, 
but alone it is unable to recognize promoter DNA and initiate transcription. Instead, the 
general transcription factors, known as TFIIB, TFIID, TFIIE, TFIIF and TFII, mediate the 
binding of Pol II to DNA. The assembly of this transcription preinitiation complex (PIC) to 
the core promoter is initiated by association of specific general transcription factors with 
specific DNA elements, such as the TATA box or other sequences that specify the 
transcription start site (TSS), and occurs in a stepwise manner, orchestrated by protein-
DNA and protein-protein interactions (Figure 6) (reviewed by Kornberg, 2007). Mediator, a 
large evolutionarily conserved complex consisting of approximately 25-30 subunits, also 
binds Pol II and general transcription factors (Figure 6), and is required for transcription of 
almost all Pol II promoters. Mediator is believed to act during assembly of the PIC. 
Mediator also provides important interaction sites for transcription factors (Figure 6), 
therefore transducing regulatory information from regulatory elements to basal transcription 
machinery on the core promoter (reviewed by Borggrefe and Yue, 2011). 
 
 
 
 
Figure 6. Schematic presentation of transcription initiation complex comprising RNA 
polymerase II, general and specific transcription factors and mediator complex. Modified 
from Kornberg (2007). 
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Specific transcription factors 
Specific nucleotide sequences, regulatory elements, in the promoter DNA are bound by 
specific transcription factors that either enhance or reduce the level of transcription, 
confirming that the gene is transcribed at the right time and at the proper level in a 
particular cell type. DNA binding domain (DBD) of the transcription factors is responsible 
for mediating the interaction with DNA. There are various structures of DBDs, including 
helix-turn-helix, homeodomain, zinc finger and beta-scaffold, and these can be used to 
classify transcription factors (Pabo and Sauer, 1992; Stegmaier et al., 2004). The regulatory 
elements to which transcription factors bind are short sequences, usually about 10 bp in 
length. These binding sequences are occupied by only a few amino acids of transcription 
factors. Regulatory elements are generally located within several hundred base pairs 
upstream from the TSS of the gene, but they can also be found tens of thousands of base 
pairs away either upstream or downstream of the coding DNA region (reviewed by 
Farnham, 2009). Depending on where transcription factors bind in the promoter, they can 
contact several proteins within the basal transcription machinery directly or they can 
interact with the basal transcription machinery through the mediator, thus enhancing DNA 
looping (Figure 6). 
Transcription factors co-operate with each other, and many transcription factors bind to 
DNA as homo- or heterodimers, increasing specificity and affinity for a cognate binding 
site. Most transcription factors are highly conserved among mammals, and they usually 
bind similar regulatory elements in different species. The conservation of regulatory 
elements between orthologous gene promoters may indicate their significant role in the 
transcriptional regulation of a certain gene (reviewed by Farnham, 2009). The activity of 
transcription factors can be regulated not only by transcription factor synthesis, but also in 
response to various extra- and intracellular signals. Growth factors, cytokines, presence or 
absence of metabolites, temperature, light, stress, oxidative stress, mechanical forces and 
xenobiotics, among others, can activate or inhibit the binding of transcription factor to the 
DNA or affect other characteristics of transcription factors to modify their activation state. 
The signalling can be mediated by a number of mechanisms, including protein 
modifications such as phosphorylation, presence of ligands and availability of transcription 
factors in the nucleus (Alberts, 2008). Transcription factors not only recruit the basal 
transcription machinery to the promoter but are also believed to stimulate transcription 
through interaction with chromatin-modifying activities (reviewed by Narlikar et al., 2002). 
1.4.1.2 Controlling the assembly and regulation of chromatin 
DNA of eukaryotes is packed into a nucleoprotein complex known as chromatin, which is 
composed of repeating units, nucleosomes (Figure 7). Each nucleosome contains 146 bp of 
DNA wrapped around histone octamers formed of two molecules of each of the core 
histones H2A, H2B, H3 and H4. Between the nucleosomes, the DNA is occupied by a 
linker histone, H1, which additionally compacts the chromatin. Chromatin plays a structural 
role, but it also plays a critical role in transcriptional regulation. Tightly packed chromatin 
restricts  the  access  of  transcription  factors  and  Pol  II  to  the  DNA  (Figure  7).  However,  
chromosome structure is dynamic and at least three processes, ATP-dependent chromatin 
remodelling, histone modifications and DNA methylation, control the assembly and 
regulation of chromatin. Ultimately, all of these processes appear to work in concert and 
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further, transcription factors are believed to participate in these processes via interactions 
with chromatin and DNA-modifying enzymes (reviewed by Paranjape et al., 1994). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Schematic representation of chromatin structure and activation of transcription 
via chromatin modifications and remodelling. Modified from Kornberg (2007). Pol II, RNA 
polymerase II.  
 
 
ATP-dependent chromatin remodelling 
Chromatin remodelling is the enzyme-assisted change in nucleosome organization and 
seems to be crucial for both the assembly of chromatin structures and their dissolution, thus 
mediating transcription by either facilitating or preventing access of transcriptional 
regulators to promoters (Figure 7). Chromatin remodelling is performed by chromatin 
remodelling complexes, which are ATP-dependent large multiprotein complexes that 
change DNA-histone interactions. In mammals, there are at least four classes of chromatin 
remodelling complexes: SWI2/SNF2, Mi-2, ISWI/SNF2 and INO80 (reviewed by Wu et 
al., 2009 and Ho and Crabtree, 2010). 
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Histone modifications 
Histone proteins are subject to a number of covalent post-translational modifications that 
occur at particular amino acid positions, primarily on the histone tails protruding from the 
nucleosome. Histone modifications are epigenetic modifications, heritable changes in DNA 
that occur without a change in the nucleotide sequence. Histone modifications can control 
chromatin packaging by altering the interactions of histones with DNA or affecting the 
contact between different histones in adjacent nucleosomes, thus enabling or blocking the 
passage of transcription machinery to the DNA. Modifications may also recruit various 
non-histone proteins and other regulatory proteins to specific chromosomal regions and 
eventually create a defined structure that is able to enhance gene expression. To date, at 
least eight different classes of modifications have been characterized, including acetylation, 
methylation, phosphorylation, ubiquitination, sumoylation, ADP ribosylation, deimination 
and proline isomerization. These modifications may act alone or in concert, being highly 
interactive, influencing and regulating each other by several mechanisms. Most of the 
histone modifications are dynamic and reversible, and various histone-modifying enzymes 
control these processes (reviewed by Bannister and Kouzarides, 2011). 
DNA methylation 
Similarly to histone modifications, DNA methylation is an epigenetic modification. It is 
associated with gene transcription and chromatin structure. DNA methylation usually 
occurs in the context of CpG dinucleotides targeting the cytosine located next to a guanine 
and describes the addition of a methyl group to the 5’ carbon of cytosine. The methylation 
targets are not equally distributed in the genome, but are found in long GC-rich sequences 
called CpG islands. In mammalian genomes, CpG islands are typically a few hundred to a 
few thousand nucleotides long and situated at significant regions of the genome, like in the 
promoters and start regions of many genes. If CpG islands are present in promoters, their 
methylation is typically associated with transcriptional silencing. Most CpG islands are 
unmethylated in normal cells, but become methylated in various cell types during 
development and differentiation and in certain pathological situations, resulting in relevant 
gene silencing (Siegfried et al., 1999; Strathdee et al., 2004). 
DNA methylation is catalysed in mammals by three DNA methyltransferases (DNMTs), 
namely  DNMT1,  DNMT3A  and  DNMT3B,  which  transfer  a  methyl  group  from  the  
universal methyl donor, S-adenmosyl-L-methionine (SAM). DNMT1 is the most abundant 
methyltransferase in mammalian cells and is generally described as maintenance DNA 
methyltransferase, whereas DNMT3A and DNMT3B are considered de novo 
methylatranferases. However, DNMT1 has well-established de novo activity, and all 
DNMTs have maintenance activity. DNMTs are associated with histone-modifying 
enzymes, including histone deacetylases, histone methyltransferases and ATP-dependent 
chromatin remodelling enzymes (reviewed by Hermann et al., 2004). 
DNA methylation can modulate the transcription of genes by preventing the transcriptional 
regulatory proteins from binding to the appropriate sequence. However, demethylation is 
not always a prerequisite for the binding of transcription factor, as sometimes 
demethylation follows the binding of transcription factor. For example, the binding of 
transcription factors Sp1 (specificity protein 1) and NF-?B (nuclear factor-?B) to their 
regulatory elements plays a role in protecting DNA from methylation (Brandeis et al., 1994; 
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Macleod et al., 1994; Kirillov et al., 1996). Transcriptional silencing by DNA methylation 
is also influenced by a protein family called methyl-CpG binding proteins, including 
MeCP2 (methyl-CpG binding protein 2), MBD1 (methyl-CpG binding domain protein) and 
MBD2. These proteins specifically bind to methylated DNA and are associated with histone 
deacetylase and methylation activities, finally forming compact, inactive silent chromatin 
(reviewed by Bogdanovic and Veenstra, 2009). 
1.4.1.3 Co-regulators 
Co-regulators are proteins that either promote or repress transcription by regulating the 
recruitment of transcription machinery or acting through chromatin modifications. Co-
regulators are characterized as co-activators or co-repressors. They do not bind to DNA, but 
usually are components of multisubunit co-regulator complexes through protein-protein 
interactions. Many co-regulators play significant roles in mediating the actions of various 
transcription factors. Depending on the cell type, target gene, DNA binding site and the 
actions of various signalling pathways, transcription factors can use distinct combinations 
of co-regulators. Many co-regulators are capable of modifying histone tails via diverse 
enzymatic activities such as acetylating/deacetylating and methylating/demethylating 
activities. Further, some co-factors have ATP-dependent remodelling activities (reviewed 
by Rosenfeld et al., 2006). 
1.4.2 Transcription factors in podocytes 
To date, a number of transcription factors specifically expressed in developing and mature 
podocytes have been identified. Further, genetic studies in mice have provided insight into 
the role of these transcription factors during kidney development and differentiation of 
podocytes and development of glomerular disease. The following sections present in more 
detail the transcription factors of specific interest in this thesis. 
1.4.2.1 WT1 
WT1, a member of the zinc finger family of transcription factors, was first identified as a 
tumour suppressor gene of Wilms’ tumour, a paediatric malignancy of the kidneys (Call et 
al., 1990; Gessler et al., 1990). WT1 also plays a crucial role in the development of several 
organ systems, including the kidney, where WT1 is suggested to play a role at multiple 
stages. At the beginning of kidney development, WT1 is expressed in the metanephric 
mesenchyme and from the S-shaped stage onward the WT1 expression is detected in 
differentiating podocytes (Pritchard-Jones et al., 1990; Pelletier et al., 1991; Armstrong et 
al., 1993; Kreidberg et al., 1993; Mundlos et al., 1993; Davies et al., 2004). WT1 
expression continues in mature podocytes and it has been shown to be crucial for 
maintaining adult glomerular structure and function (Mundlos et al., 1993; Chau et al., 
2011). WT1 regulates nephrin and podocalyxin in podocytes (Palmer et al., 2001; Guo et 
al., 2004; Wagner et al., 2004). 
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Binding of WT1 to DNA is mediated by its zinc finger region. WT1 generally recognizes 
GC-rich sequences and rarely other binding sequences (Rauscher et al., 1990; Wang et al., 
1993; Hamilton et al., 1995; Nakagama et al., 1995). WT1 has at least 24 different isoforms 
resulting from alternative splicing, RNA editing and an alternative translation start site. 
Isoforms seem to have different and sometimes overlapping functions and their expressions 
have tissue-, developmental stage- and species-specific differences (Kent et al., 1995; 
Renshaw et al., 1997). Four major isoforms are produced by alternative splicing events 
occurring in two different sites, in exon 5 and exon 9 (Haber et al., 1991). Exon 5 encodes 
17 amino acids and alternative splicing results in the presence or absence of this amino acid 
sequence in between the transactivation domain (TAD) and the zinc finger region. An 
alternative splicing event occuring in a splice donor site at the end of exon 9 gives rise to 
isoforms differing by three amino acids, lysine-threonine-serine (KTS), between the third 
and fourth zinc finger (Haber et al., 1991). The KTS sequence changes the structure of the 
zinc finger domain, altering its DNA binding capabilities, and the isoform that lacks the 
KTS tripeptide (KTS–) is suggested to have a stronger effect on transcriptional regulation 
(Drummond et al., 1994; Laity et al., 2000). 
In addition to Wilms’ tumour at least three other human diseases are associated with 
mutations in WT1. Denys-Drash syndrome (DDS) results from mutations in the zinc finger 
region of WT1, indicating that DDS occurs as a result of altered or severely impaired DNA 
binding activity of WT1 (Pelletier et al., 1991; Little et al., 1993; Bardeesy et al., 1994). 
DDS is characterized by diffuse mesangial sclerosis within the glomeruli and patients 
develop partial gonadal dysgenesis, nephropathy and frequently also Wilms’ tumour (Drash 
et al., 1970). WAGR syndrome is a combination of Wilms’ tumour, aniridia, genitourinary 
abnormalities and mental retardation and results from chromosomal deletions of variable 
size at locus 11p13 (Crolla and van Heyningen, 2002). Mutation in the splice donor site in 
intron 9 of the WT1 gene results in a higher ratio of the KTS– splice isoform over KTS+ 
and leads to Frasier syndrome. Patients with Frasier syndrome typically have focal 
segmental glomerular sclerosis and pseudohermaphroditism (Barbaux et al., 1997; Klamt et 
al., 1998). 
A large number of different types of Wt1-mutant or -deficient mice have been studied, and 
they show diverse phenotypes and contradictory results with respect to the role of WT1 in 
kidney development. This may be due to the complex nature of WT1 and the lack of 
sufficient knowledge of the role of various WT1 isoforms in different biological processes 
and also a lack of information about co-operation of WT1 with other regulatory proteins 
and downstream targets of WT1. Mice homozygous null for WT1 die in utero at 
midgestation on E13.5 because of cardiac abnormality, and mice fail to develop kidneys 
(Kreidberg et al., 1993). This early lethal phenotype has been rescued using a human-
derived WT1 YAC construct and these mice survive until birth. The mice have kidneys, but 
differentiated podocytes are not observed. Studies on these rescued mice demonstrate that 
WT1 is required continuously during nephrogenesis, in particular, in specification and 
maturation of the podocyte lineage (Moore et al., 1999). Ageing mice heterozygous for 
WT1 develop glomerulosclerosis and show proteinuria and podocyte foot process 
effacement. Further, nephrin and CD2AP are down-regulated in these mice (Menke et al., 
2003). Transgenic mice expressing a mutant form of WT1 in podocytes have abnormally 
developed glomeruli and defects in capillary development, but the expression levels of 
nephrin, podocin, CD2AP, synaptopodin and podocalyxin are unaffected. This suggests that 
during the development of glomeruli, WT1 is involved in capillary formation, regulating 
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the expression of growth factors that affect capillary development (Natoli et al., 2002a). In 
terms of the role of different WT1 isoforms in kidney development, mice lacking exon 5 
develop normally (Natoli et al., 2002b). Heterozygous transgenic mice expressing only 
KTS+ or KTS– isoforms show abnormal glomerular development, but KTS– null mice 
have a more severe phenotype, suggesting that there may be an earlier requirement for the 
KTS– isoform or the KTS– isoform may have a broader role during glomerular 
development. The expression of nephrin was decreased in both knock-out mice (Hammes et 
al., 2001). Altogether, these mouse models demonstrate the critical role of WT1 during 
kidney development. Very recently, WT1 was deleted ubiquitously in adult mice. The 
development of the kidney phenotype in these mice was extremely rapid and mice exhibited 
severe proteinuria, loss of podocyte foot processes and had hardly any nephrin and 
synaptopodin expression in the podocytes. This provides evidence that WT1 is crucial also 
for adult glomerular structure and function (Chau et al., 2011). 
1.4.2.2 NF-?B 
NF-?B (nuclear factor-?B), a member of a beta-scaffold transcription factor family, was 
initially identified as a DNA-binding factor for the enhancer of the Ig-light chain activated 
in B-cells (Sen and Baltimore, 1986). Nowadays, NF-?B is considered a stimulus-
responsive pleiotropic regulator of gene control. It is present in all cell types, playing a 
significant role in promoting the expression of a number of genes involved in immune and 
inflammatory responses and in cell proliferation, differentiation and apoptosis. The NF-?B 
family consists of five members, p50/p105, p52/p100, p65 (RelA), c-Rel and RelB, which 
share an N-terminal highly conserved Rel homology domain (RHD) responsible for DNA 
binding and dimerization (reviewed by Gilmore, 2006 and Hayden and Ghosh, 2008). The 
transcription activation domain (TAD) is present only in the C-terminal domains of the so-
called Rel proteins of this family, p65, c-Rel and RelB. p105 and p100 represent the 
precursors for p50 and p52, respectively, and contain in C-terminal segment multiple copies 
of ankyrin repeats, which act to inhibit these proteins. In a proteolytic process occurring in 
the cytoplasm, the C-terminal segments of p105 and p100 are degraded, and these proteins 
become the shorter, active DNA-binding proteins p50 and p52 (Blank et al., 1991; Fan and 
Maniatis, 1991; Palombella et al., 1994). As p50/p105 and p52/p100 lack TAD, they are 
generally not activators of transcription unless they are associated with Rel proteins or other 
proteins capable of co-activator recruitment. 
NF-?B functions as a homo- or heterodimer when it is able to bind to 10 base pair response 
element with a great amount of variability (5’ -GGGRNNYYCC -3’; R = A or G, N = any 
nucleotide, Y = C or T). All NF-?B family members can form homodimers or 
heterodimers, except RelB, which only forms heterodimers. p50 and p65 are the most 
abundant subunits, and their homo- and heterodimers are the major NF-?B dimers in many 
cells, including podocytes (Baldwin, 1996; Karin and Ben-Neriah, 2000; Mudge et al., 
2001; Martinka and Bruggeman, 2006; Hussain et al., 2009). The combinatorial diversity of 
NF-?B proteins gives rise to the complex nature of NF-?B. Different dimers can have 
distinct DNA-binding site specificities or specific needs for certain co-regulators, or there 
can be different dimers acting in specific physiological conditions. 
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NF-?B is an inducible transcription factor, and its activity is controlled by interaction with 
inhibitory proteins of the I?B family. In its inactive state, NF-?B is bound to I?B in the 
cytoplasm,  but  in  response  to  a  large  variety  of  stimuli,  such  as  stress,  cytokines  and  
viruses, I?B becomes degraded and NF-?B is translocated to the nucleus. The I?B family 
consists of I???, I???, I???, I???, Bcl-3 and the precursors p105 and p100. They all 
contain multiple ankyrin repeats by which they interact with the Rel homology region, 
masking the nuclear localization signal of the NF-?B dimer. All I?B family members have 
different affinities for individual NF-?B dimers and I??? is the best-characterized member 
of the group (reviewed by Hayden and Ghosh, 2008). I??? knock-out mice are born 
normally but usually die a few days after birth due to extensive skin inflammation 
consistent with persistent NF-?B activation (Klement et al., 1996). 
NF-?B is activated via two main pathways: the classical/canonical pathway and the 
alternative/non-canonical pathway. The classical pathway is usually rapid and mostly 
targets p50/p65 and p50/c-Rel dimers and is triggered by pro-inflammatory cytokines, such 
as TNF-? (tumour necrosis factor-?) and IL-1 (interleukin-1), as well as microbial products. 
Upon receptor stimulation, I?B kinase (IKK) complex, consisting of catalytic kinase 
subunits IKK? and/or IKK? and a scaffold, sensing protein called NF-?B essential 
modulator (NEMO), is activated, leading to phosphorylation of I?B at two serine residues. 
This results in ubiquitination and degradation of I?B by the proteasomes and NF-?B is then 
free to enter the nucleus. The alternative NF-?B pathway involves slow activation, and it 
targets the p100/RelB complex. This pathway is activated by a more limited number of 
stimuli and is mainly involved during B- and T-cell organ development. In this pathway, 
activation of NF-?B-inducing kinase (NIK) leads to phosphorylation and activation of 
IKK? homodimer complex, resulting in the phosphorylation of p100 at two serine residues, 
subsequently leading to a proteasomal degradation of the C-terminal part of p100 and 
liberation of the p52/RelB complex (reviewed by Gilmore, 2006). 
The  role  of  NF-?B  in  podocytes  has  been  previously  investigated  in  mouse  models.  No  
renal phenotype has been reported in mouse models deficient in any NF-?B genes 
(Gerondakis et al., 1999), but constitutive activation of NF-?B in mice, resulting from 
removal of a natural NF-?B pathway inhibitor Par4, causes proteinuria and podocyte foot 
process effacement. Nephrin expression is down-regulated in the podocytes of these mice 
(Hussain et al., 2009). NF-?B activation in podocytes has been reported in the pathogenesis 
of human kidney diseases, such as diabetic nephropathy (Mezzano et al., 2004), lupus 
nephritis and non-proliferative glomerulopathy (Zheng et al., 2006) and in experimental 
kidney disease models, including a passive Heyman nephritis model in rats (Mudge et al., 
2001), a 5/6 renal ablation model (Fujihara et al., 2007) and HIV-associated nephropathy 
(Martinka and Bruggeman, 2006). Increased NF-?B accumulation in the nuclei of 
podocytes has also been linked to ageing glomeruli (Wiggins et al., 2010). Moreover, NF-
?B has been suggested to be important for activating the expression of WT1, but results 
have been controversial (Dehbi et al., 1998; Chen and Williams, 2000). 
1.4.2.3 Sp1 
Sp1 (specificity protein 1) is a member of the Sp family of transcription factors. This family 
has a particular combination of three conserved Cys2His2 zinc fingers representing a DNA-
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binding domain. Sp1 is ubiquitously expressed in mammalian cells and initially was 
considered a constitutive activator of housekeeping genes. However, it is now clear that 
Sp1 is involved also in regulating expression of many tissue-specific and inducible genes. 
Sp1 binds to GC-rich motifs and many promoters of Sp1-regulated genes lack TATA box 
(reviewed by Suske, 1999). 
A role for Sp1 in nephrogenesis has been proposed since during nephrogenesis Sp1 is 
expressed in developing podocytes. The expression overlaps with that of WT1, and Sp1 is 
able to regulate WT1 (Cohen et al., 1997). Sp1 is expressed in podocytes in adult rat kidney 
(Cohen et al., 1997), and it also plays a role in regulating transcription of podocyte 
molecules CD2AP and podocalyxin (Butta et al., 2006; Lu et al., 2008; Su et al., 2009). 
1.4.2.4 Other transcription factors 
Pax2 is a member of the paired box (Pax) family of transcription factors and plays an 
essential role in kidney development since Pax2-null mice lack kidneys, ureters and genital 
tracts (Torres et al., 1995). During kidney development Pax2 expression becomes down-
regulated in podocyte precursors simultaneously with a marked increase in WT1, 
suggesting that Pax2 could be a target gene for WT1 (Ryan et al., 1995; Donovan et al., 
1999). Pax2 down-regulation is speculated to be required for proper podocyte maturation 
because the synthesis of Pax2 in transgenic mice results in podocyte damage (Dressler et 
al., 1993) and reactivation of Pax2 in terminally differentiated podocytes has been linked to 
formation of a more dedifferentiated phenotype (Wagner et al., 2006). Pax2 is shown to 
interact with an adaptor protein Pax transactivation domain interacting protein (PTIP), 
promoting assembly of the histone H3K4 methyltransferase complex. This suggests that 
Pax2 could provide the locus and tissue specificity for histone methylation, thus 
establishing a kidney-specific fate (Patel et al., 2007). Very recently, PTIP was 
conditionally deleted in podocytes in mice. Renal development and function were not 
impaired in young mice (aged 3 months), but in older mice (aged 6 and 12 months) deletion 
led to proteinuria and podocyte foot process effacement. Nephrin expression was partially 
depleted in these mice (Lefevre et al., 2010). 
LMX1B is a LIM-homeodomain transcription factor, mutations of which are responsible 
for nail-patella syndrome (NPS). Up to 40% of NPS patients exhibit kidney abnormalities, 
including proteinuria and disappearance of podocyte foot processes (Chen et al., 1998; 
Dreyer et al., 1998; Vollrath et al., 1998; Sweeney et al., 2003). Conventional knock-out of 
Lmx1b in mice leads to lack of normal podocyte foot processes and SDs, and mice die 
within 24 h of birth (Chen et al., 1998; Miner et al., 2002; Rohr et al., 2002). Podocyte-
specific knock-out of Lmx1b in mice leads to survival for up to 2 weeks after birth, and the 
podocytes develop foot processes initially but subsequently lose them (Suleiman et al., 
2007). These results suggest that LMX1B is important for the initial differentiation of 
podocytes, but also for maintenance of the podocyte phenotype. A physical interaction 
between LMX1B and Pax2 has been demonstrated, suggesting that they could act together 
at some embryonal stage (Marini et al., 2005). Podocyte molecules podocin and CD2AP are 
suggested to be regulated by LMX1B, even though the results have been controversial 
(Miner et al., 2002; Rohr et al., 2002; Heidet et al., 2003; Suleiman et al., 2007; Harendza 
et al., 2009).  
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Kreisler (also called MafB or Maf-1) is a member of the Maf family of transcription factors 
that is expressed in developing and mature podocytes (Imaki et al., 2000). The inactivation 
of Kreisler in mice results in proteinuria and loss of podocyte foot processes, demonstrating 
that Kreisler is essential for podocyte differentiation. Podocyte molecules nephrin, podocin 
and CD2AP are down-regulated in mice lacking Kreisler, suggesting that they could 
represent direct or indirect targets of Kreisler (Sadl et al., 2002; Moriguchi et al., 2006).  
Pod1 (also known as epicardin and capsulin) is a transcription factor of the basic helix-
loop-helix family showing expression in podocyte precursors during kidney development as 
well as in podocytes of adult kidneys (Quaggin et al., 1998). Pod1 knock-out mice die at 
birth  as  a  result  of  heart  and  lung  defects,  but  they  also  possess  major  renal  defects.  
Podocytes are formed, but they remain columnar-shaped and form only a few foot 
processes, suggesting that Pod1 plays an important role in kidney morphogenesis and 
differentiation of podocytes (Quaggin et al., 1999).  
Foxc2 is a member of the forkhead box (FOX) transcription factor family. Foxc2 is 
expressed in developing and mature podocytes (Takemoto et al., 2006) and is suggested to 
have a role in podocyte differentiation since podocytes in mice lacking Foxc2 fail to form 
foot processes (Takemoto et al., 2006). Recently, using Xenopus pronephrons and zebrafish 
as models for podocyte development, the interplay between Foxc2 and WT1 and Notch 
signalling was demonstrated to be important for podocyte development (White et al., 2010; 
O'Brien et al., 2011). 
1.4.3 Transcriptional regulation of nephrin and Neph3 genes 
Several studies have focused on identifying transcription factors and agents and underlying 
mechanisms responsible for regulating the nephrin gene in podocytes of man and rodents, 
but the transcriptional regulation of the Neph3 gene in podocytes has thus far not been 
elucidated. Outside the podocytes, the transcriptional regulation of nephrin and Neph3 
genes has been studied only in the developing central nervous system (Nishida et al., 2010). 
1.4.3.1 Tissue-specific regulatory elements in nephrin promoter 
Soon after discovery of nephrin, several studies have concentrated on identifying and 
characterizing regulatory sequences responsible for its tissue-specific expression. Wong et 
al. (2000) observed that the 1.25-kb fragment of the human nephrin proximal promoter 
directs the lacZ gene to glomeruli and specifically to podocytes. Later, Guo et al. (2004) 
demonstrated that a highly conserved 186-bp fragment within this region (locating -667 bp 
upstream of the TSS) drives the expression in podocytes. Using a mouse nephrin sequence, 
it was first shown that 8.3-kb and 5.4-kb promoter fragments drive podocyte-specific 
expression in the kidney, but the expression of these fragments was also detected in the 
pancreas and in structures of the developing and adult brain (Moeller et al., 2000; Putaala et 
al., 2001). Later, a 1.25-kb fragment of the mouse nephrin promoter was shown to drive the 
expression solely in podocytes (Moeller et al., 2002). Beltcheva and co-workers (2003) 
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have also used different fragments of the mouse nephrin promoter to identify the sequence 
essential for podocyte-specific expression. They demonstrated that 6.242-kb and 4.013-kb 
fragments are sufficient for driving expression in the podocytes, central nervous system and 
pancreas. However, in their experiments, in disagreement with other studies, 2.148-kb 
fragment did not yield expression in podocytes, or in any other tissues. Taken together, 
nephrin seems to have distinct promoter regions for tissue-specific expression. 
1.4.3.2  Transcription factors and agents regulating nephrin gene in podocytes 
Transcription factors in nephrin gene regulation 
Two studies show that transcription factor WT1 is an important regulator of the nephrin 
gene  (Guo et  al.,  2004;  Wagner  et  al.,  2004).  Guo et  al.  (2004)  at  the  same time as  they  
found a 186-bp human nephrin promoter fragment capable of driving podocyte-specific 
expression identified within this 186-bp fragment an 83-bp area with 83% sequence 
homology between humans and mice and harbouring a putative binding site for WT1 at 
position -654 to -638 bp upstream from the human nephrin TSS. They further demonstrated 
that WT1 can bind in vitro to this region in the human sequence and activate the human 
nephrin promoter. Wagner et al. (2004), by contrast, showed a putative WT1 binding site at 
position -1043 to -1022 bp upstream from the mouse nephrin TSS. This element is not 
located in the homological region that Guo et al. (2004) identified, but approximately 600 
bp upstream from it. However, Wagner et al. (2004) showed that this putative WT1 binding 
site is bound by WT1, and WT1 transactivates the mouse nephrin promoter via this 
element. The importance of this element was also demonstrated in vivo,  showing that it  is 
required for direct podocyte-specific expression in transgenic mice. Further, nephrin 
mRNA expression has been shown to be down-regulated in kidneys lacking either KTS+ or 
KTS– isoform of WT1 and the expression was lower in mice deficient for KTS– than for 
KTS+ (Wagner et al., 2004). 
Beltcheva et al. (2010) analysed in more detail the mouse nephrin promoter region which 
they had previously found to be important for podocyte-specific expression (Beltcheva et 
al., 2003). Within the region between -4 and -2.1 kb upstream from the major TSS, a 237-
bp area highly homologous with the human sequence was identified. This region is located 
in the mouse sequence between nucleotides -2299 and -2063, and a putative binding site for 
Sp1 was located within it at position -2133/-2103. Sp1 was shown to bind this element in 
vitro, suggesting a role for Sp1 in nephrin gene regulation. 
Snail, a transcription factor implicated in regulating cell adhesion and the epithelial to 
mesenchymal transition, is linked to the regulation of the nephrin gene in injured 
podocytes. The expression of nephrin mRNA and protein was down-regulated and Snail 
protein expression up-regulated in the podocytes of rats with puromycin aminonucleoside 
(PA)-induced nephrosis, an experimental model showing podocyte injury. In vitro assays 
indicate that Snail represses rat nephrin promoter activity and binds possibly to E-box sites 
in the coding region of the rat nephrin gene between nucleotides +404 and +972 (Matsui et 
al., 2007). 
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Agents in nephrin gene regulation 
To identify regulators of nephrin gene expression, Yamauchi et al. (2006) performed 
extensive studies in conditionally immortalized mouse podocytes expressing SEAP 
(secreted alkaline phosphatase) reporter gene under the control of the mouse nephrin 
promoter (reporter mouse podocytes). They found that both nephrin promoter activity and 
mRNA expression were increased by all-trans retinoic acid (ATRA), 1,25-
dihydroxyvitamin D3 and dexamethasone and also demonstrated that any combination of 
these agents further induced nephrin promoter activity. A couple of years later, studies from 
the same group using the same reporter mouse podocytes as a model system suggested that 
ATRA induces nephrin promoter activity through retinoic acid receptor (RAR) and 1,25-
dihydroxyvitamin D3 through co-operation of vitamin D receptor (VDR) and RAR. 
Elements for RAR and VDR in the mouse nephrin promoter were not specified in this study 
(Okamura et al., 2009). Very recently, another group shed light on the mechanisms 
underlying 1,25-dihydroxyvitamin D3 up-regulation of nephrin mRNA and protein 
expression in cultured mouse podocytes. Deb et al. (2011) showed that VDR-RXR (retinoic 
X receptor) heterodimer binds to the VDR element (VDRE) located at position -327/-312 in 
the mouse nephrin promoter and further demonstrated that 1,25-dihydroxyvitamin D3 
treatment strongly induces nephrin promoter activity containing this VDRE and leads to 
increased binding of VDR to this element. In vivo validation with mice confirmed that in 
podocytes 1,25-dihydroxyvitamin D3 stimulates nephrin mRNA and protein expression by 
acting on a VDRE (Deb et al., 2011). Two studies of ATRA and nephrin mRNA and 
protein expression have concentrated more on the therapeutic effects of ATRA in various 
animal models of kidney diseases. In rats with PA-induced nephrosis, the expression of 
nephrin mRNA was decreased, but treatment with ATRA maintained nephrin expression as 
well as prevented proteinuria. Human nephrin promoter was found to harbour at least three 
putative binding sites for RAR (RARE), at positions -1260/-1246, -1041/-1021 and             
-774/-757, and the activity of the promoter regions containing these elements was shown to 
be augmented by ATRA in HeLa cells (Suzuki et al., 2003). Another study revealed that 
nephrin protein expression is increased by ATRA in cultured mouse and rat podocytes. 
ATRA also reduces proliferation and induces differentiation of cultured podocytes 
(Vaughan et al., 2005). In vivo studies in the antibody-mediated mouse model of podocyte 
injury demonstrated that ATRA prevents the decrease in nephrin protein expression 
(Vaughan et al., 2005). 
Inflammatory cytokines have also been shown to be involved in nephrin regulation. Using 
human embryonic A293 kidney cells, TNF-? and IL-1? were found to up-regulate nephrin 
mRNA and protein expression, and this up-regulation apparently involved a rottlerin-
sensitive protein kinase. In the same study, nephrin mRNA and protein expression was up-
regulated by IL-1? also in a primary culture of human podocytes (Huwiler et al., 2003). In 
contrast to research in human cell lines, studies on mouse podocytes show that nephrin 
promoter activity and mRNA expression are decreased by TNF-? and IL-1? (Yamauchi et 
al., 2006). Using reporter mouse podocytes, it has further been shown that macrophages 
suppress nephrin promoter activity possibly via production of TNF-? and IL-1?. 
Involvement of the PI3K/AKT pathway is speculated in the suppression of the nephrin gene 
by these cytokines (Takano et al., 2007). The same group recently showed that in reporter 
mouse podocytes TNF-? represses RAR activity and suggested that nephrin gene 
suppression by TNF-? is caused at least partly through inhibition of the cAMP-RAR 
pathway (Saito et al., 2010). 
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Two studies show the involvement of peroxisome proliferator-activated receptors (PPARs) 
in nephrin regulation. In cultured human podocytes and human embryonic A293 kidney 
cells, PPAR? stimulates nephrin mRNA and protein expression. The action of PPAR? was 
suggested to result from increased nephrin promoter activity and/or increased stabilization 
of nephrin mRNA (Ren et al., 2005). Benigni et al. (2006) showed that in human HK-2 
cells, pioglitazone, a ligand of PPAR?, increases the activity of human nephrin proximal 
promoter, which contains a putative peroxisome proliferator-responsive element (PPRE). 
Pioglitazone-induced binding of PPAR/RXR heterodimer to this PPRE was demonstrated. 
Further, in vivo studies using passive Heymann nephrosis (PHN) rats, an immune model of 
progressive nephropathy, demonstrated decreased nephrin mRNA and protein expression in 
glomeruli of PHN rats, but pioglitazone restored the expression, suggesting a renoprotective 
effect of PPAR? via enhanced nephrin expression through PPRE (Benigni et al., 2006). 
1.4.3.3 Transcription factors regulating nephrin and Neph3 genes in other tissues 
Ptf1a, a basic helix-loop-helix transcription factor that plays an indispensable role in 
neuronal development, controls nephrin and Neph3 gene expression in the developing 
central nervous system of mice. Ptf1a and nephrin and Neph3 mRNA are expressed in 
overlapping regions and the same cells in the mouse developing cerebellum, hindbrain, 
spinal cord, retina and hypothalamus. In Ptf1a-null mice, the expression of nephrin and 
Neph3 mRNA was lost in these regions. In vivo and in vitro, Ptf1a was shown to bind to the 
Ptf1a binding element located about 1.8 kb upstream from the major nephrin TSS in the 
shared 5’-flanking region of the nephrin and Neph3 mouse genes. Further, Ptf1a drove the 
promoter activity of this region in both directions (Nishida et al., 2010). 
1.4.4 Summary of transcription factors and agents of interest 
A number of transcription factors expressed in developing and mature podocytes play a role 
in kidney development, kidney maintenance and/or glomerular disease development. Some 
of these regulate nephrin or other podocyte molecules. There are also many agents involved 
in nephrin regulation. Tables 1 and 2 summarize the transcription factors and agents of 
interest in this thesis. 
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Table 1. Summary of transcription factors of interest. 
 
 Description 
WT1 ? Crucial during kidney development and for maintaining the integrity of mature podocytes 
(Prichard-Jones et al., 1990; Pelletier et al., 1991; Kreidberg et al., 1993; Davies et al., 2004; 
Chau et al., 2011) 
? Regulates nephrin and podocalyxin (Palmer et al., 2001; Guo et al., 2004; Wagner et al., 2004) 
NF-?B ? Activated in podocytes in human and experimental kidney diseases (Mudge et al., 2001; 
Mezzano et al., 2004; Martinka and Bruggeman, 2006; Zheng et al., 2006; Fujihara et al., 2007) 
? May be important for activating WT1 expression (Dehbi et al., 1998; Chen and Williams, 2000) 
Sp1 ? Proposed to play a role in nephrogenesis (Cohen et al., 1997) 
? Regulates nephrin, WT1, CD2AP and podocalyxin (Cohen et al., 1997; Butta et al., 2006; Lu et 
al., 2008; Su et al., 2009; Beltcheva et al., 2010) 
Pax2 ? Essential role in kidney development (Torres et al., 1995) 
? Down-regulation during kidney development is suggested to be needed for proper podocyte 
maturation (Dressler et al., 1993; Ryan et al., 1995; Donovan et al., 1999). 
LMX1B ? Suggested to be important for the initial differentiation of podocytes and the maintenance of the 
podocyte phenotype (Chen et al., 1998; Miner et al., 2002; Rohr et al., 2002; Suleiman et al., 
2007) 
? Interacts physically with Pax2 (Marini et al., 2005) 
? May regulate podocin and CD2AP (Miner et al., 2002; Rohr et al., 2002; Heidet et al., 2003; 
Suleiman et al., 2007; Harendza et al., 2009) 
Kreisler ? Essential for podocyte differentiation (Imaki et al., 2000) 
Pod1 ? Important role in kidney morphogenesis and differentiation of podocytes (Quaggin et al., 1999) 
Foxc2 ? Suggested to have a role in podocyte differentiation (Takemoto et al., 2006) 
? Interplay with WT1 and Notch signalling is important for podocyte development in Xenopus 
pronephrons and zebrafish (White et al., 2010; O'Brien et al., 2011) 
Snail ? Down-regulates nephrin in injured rat podocytes (Matsui et al., 2007) 
Ptf1a ? Regulates nephrin and Neph3 genes in the developing central nervous system of the mouse 
(Nishida et al., 2010) 
 
Table 2. Summary of agents regulating nephrin mRNA and protein expression. 
 
 Description 
ATRA ? Increases the activity of human and mouse nephrin promoter activity through RARE 
(Suzuki et al., 2003; Yamauchi et al., 2006; Okamura et al., 2009) 
? Prevents the decrease in nephrin mRNA and protein expression in murine models of 
kidney diseases (Suzuki et al., 2003; Vaughan et al., 2005) 
1,25(OH)2D3 ? Induces mouse nephrin promoter through co-operation of VDR and RAR (Yamauchi et 
al., 2006; Okamura et al., 2009) 
? Stimulates nephrin mRNA and protein expression in mouse podocytes by acting on a 
VDRE (Deb et al., 2011) 
Dexamethasone ? Induces mouse nephrin promoter activity and mRNA expression (Yamauchi et al., 2006) 
TNF-? ? Up-regulates nephrin mRNA and protein expression in A293 cells (Huwiler et al., 2003) 
? Down-regulates nephrin promoter activity and mRNA expression in mouse podocytes 
(Yamauchi et al., 2006) 
IL-1? ? Up-regulates nephrin mRNA and protein expression in A293 cells and primary culture of 
human podocytes (Huwiler et al., 2003) 
? Down-regulates nephrin promoter activity and mRNA expression in mouse podocytes 
(Yamauchi et al., 2006) 
PPAR ? PPAR? stimulates nephrin mRNA and protein expression in cultured human podocytes 
and A293 cells (Ren et al., 2005) 
? Pioglitazone, a ligand of PPAR?, increases the activity of human nephrin promoter and 
restores decreased nephrin mRNA and protein expression in glomeruli of PHN rats 
(Benigni et al., 2006) 
ATRA, all-trans retinoic acid; RAR(E), retinoic acid receptor (element); 1,25(OH)2D3,1,25-dihydroxyvitamin 
D3;VDR, vitamin D receptor; TNF-?, tumor necrosis factor-?; IL-1?, interleukin-1?; PPAR, peroxisome 
proliferator-activated receptor; PHN, passive Heymann nephrosis 
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2 AIMS OF THE STUDY 
 
 
Nephrin and the members of the Neph-protein family, Neph1-3, are essential structural and 
signalling components in the slit diaphragm (SD) of the kidney filtration barrier. This thesis 
aimed at determining whether Neph3 has similar functions as nephrin and other Neph-
family members. The study also focused on the transcriptional regulation of nephrin and 
Neph3 genes. Based on the chromosomal location of nephrin and Neph3 genes and the 
similar functions of their protein products, the study aimed at identifying common 
mechanisms in the transcriptional regulation of nephrin and Neph3 genes. Specific 
objectives were as follows: 
1. To investigate the interactions and cell adhesion activities of nephrin and Neph-
family members 
2. To identify and characterize the key regulatory region(s) involved in constitutive 
transcription of the Neph3 gene 
3. To identify common transcriptional mechanisms and factors regulating nephrin and 
Neph3 genes 
4. To evaluate the role of DNA methylation in regulating nephrin and Neph3 genes 
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3 MATERIALS AND METHODS 
3.1 DNA constructs 
3.1.1 Expression vectors (I-IV) 
Full-length and different parts of nephrin, Neph1 and Neph3 genes were subcloned into 
mammalian expression vectors as detailed in Study I. These vectors were used in retrovirus 
production and to produce proteins for protein-protein interaction studies. Expression 
vectors for various transcription factors were obtained via collaboration and used to 
evaluate their role in nephrin and Neph3 gene regulation and their protein-protein 
interactions (Studies II-IV). The expression vectors are listed in Table 3. 
Table 3. Summary of expression vectors used in Studies I-IV. 
 
Gene 
(Vector backbone) 
Species Description Vector backbone supplier / 
Construct provider 
Study 
EGFP 
(pMSCVpuro) 
jellyfish full-length Clontech Laboratories (Mountain 
View, CA, USA) 
I 
Nephrin     
 (pcDNA3.1/Myc-His) rat full-length Invitrogen (Carlsbad, CA, USA) I 
 (pMSCVneo) rat full-length Clontech Laboratories I 
 (derivative of pCDM8) human intracellular domain (Tsiokas et al., 1997) I 
Neph1     
 (pBabe-hygro) mouse full-length, HA-tagged (Morgenstern et al., 1990) I 
 (derivative of pCDM8) human intracellular domain (Tsiokas et al., 1997) I 
Neph3     
 (pcDNA3.1/Myc-His) mouse full-length Invitrogen I 
 (pMSCVpuro) mouse full-length, EGFP-tagged Clontech Laboratories I 
 (derivative of pCDM8) human intracellular domain (Tsiokas et al., 1997) I 
 (signal plgplus) human extracellular domain R&D Systems (Minneapolis, MN, 
USA) 
I 
Sp1 
(pPAC) 
human full-length Guntram Suske, Philipps-
Universität Marburg, Germany 
II 
NF-?B p50 
(pcDNA3.1) 
human full-length Alan Krensky, Stanford University 
School of Medicine, CA, USA 
II, III 
NF-?B p65 
(pcDNA3.1) 
human full-length Alan Krensky, Stanford University 
School of Medicine, CA, USA 
II, III 
WT1 
(pcDNA3) 
human isoform WT1(+/–) Charles Roberts, Oregon Health 
and Science University, OR, USA 
III 
GABP? 
(pCR3.1E) 
human full-length Toshibumi Shimokawa and Chisei 
Ra, Nihon University Graduate 
School of Medical Sciences, Japan 
IV 
GABP? 
(pCR3.1E) 
human full-length Toshibumi Shimokawa and Chisei 
Ra, Nihon University Graduate 
School of Medical Sciences, Japan  
IV 
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3.1.2 Luciferase reporter gene constructs (II-IV) 
To identify and characterize the promoter regions important for the regulatory processes of 
nephrin and Neph3 genes, a series of nephrin and Neph3 luciferase reporter gene constructs 
was created. Site-directed mutagenesis of putative transcription factor binding sites was 
performed with the QuikChangeTM site-directed mutagenesis kit (Stratagene, La Jolla, CA, 
USA) using mutated oligonucleotides. The detailed cloning processes of all constructs, 
including the primers used, are described in the original publications II-IV. The constructs 
are listed in Table 4. 
Table 4. Reporter gene constructs used in Studies II-IV. Numbers from/to indicate the 
distance in base pairs related to the nephrin and Neph3 transcription start site. 
 
Reporter gene construct From To Mutation Study 
Neph3 -5070 +48  II 
 -4543 +48  II 
 -3877 +48  II 
 -2260 +48  II 
 -1072 +48  II 
 -536 +48  II 
 -366 +48  II 
 -162 +48  II, III 
 -105 +48  II 
 -105 +48 Sp1 mut II 
 -105 +48 NF-?B mut II 
 -105 +48 Sp1 mut, NF-?B mut II 
 -57 +48  II 
Nephrin -837 +156  III, IV 
 -617 +156  unpublished data 
 -392 +156  IV 
 -48 +156  IV 
 -48 +156 Ets(1) mut IV 
 -48 +156 Ets(2) mut IV 
 -48 +156 Ets(3) mut IV 
 +25 +156  IV 
 
3.2 Cell culture (I-IV) 
Several cell lines were used to investigate the protein-protein interactions and the adhesive 
properties of nephrin, Neph1 and Neph3, and the transcriptional regulation of nephrin and 
Neph3 genes. The cell lines used and their culture media are shown in Table 5. 293T cells, 
L-cells, Phoenix ampho cells and A293 cells were maintained in 5% CO2 at 37°C, and S2 
cells at 25°C without CO2. Human podocytes were cultured at 33°C (undifferentiated 
podocytes) and differentiated at 37°C for 14 days in 5% CO2. 
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Table 5. Summary of cell lines used in Studies I-IV. 
 
Cell line Culture medium Reference / 
supplier 
Study 
293T (Highly transfectable 
derivative of the human 
embryonic kidney 293 cell 
line) 
Dulbecco’s Modified Eagle’s Medium 
(DMEM) (glucose 4500 mg/l) 
supplemented with 10% foetal bovine 
serum, 2 mM glutamine, 25 mM HEPES 
(pH 7.5), 100 U/ml penicillin and 100 
?g/ml streptomycin 
ATCC I 
L-cells (Mouse L fibroblasts; 
L-929) 
DMEM (glucose 4500 mg/l) 
supplemented with 10% foetal bovine 
serum, 2 mM glutamine, 25 mM HEPES 
(pH 7.5), 100 U/ml penicillin and 100 
?g/ml streptomycin 
ATCC I 
Phoenix ampho packaging 
cells (Highly transfectable 
derivative of the 293T cell line 
for retrovirus production) 
DMEM (glucose 4500 mg/l) 
supplemented with 10% foetal bovine 
serum, 2 mM glutamine, 100 U/ml 
penicillin and 100 ?g/ml streptomycin 
Garry Nolan, 
Stanford University, 
CA, USA 
I 
S2 cells (Drosophila 
Schneider 2 cells) 
Express Five serum-free medium (SFM) 
supplemented with 10% foetal bovine 
serum, 2 mM glutamine, 100 U/ml 
penicillin and 100 ?g/ml streptomycin 
Jussi Taipale, 
University of 
Helsinki, Finland 
II 
A293 (Human embryonic 
kidney cells) 
RPMI 1640 medium supplemented with 
10% foetal bovine serum, 2 mM 
glutamine, 100 U/ml penicillin and 100 
?g/ml streptomycin 
(Wang et al., 2001) II, III, IV 
Human podocytes RPMI 1640 medium containing L-
glutamine supplemented with 10% 
foetal bovine serum and insulin, 
transferrin and selenite 
(Saleem et al., 2002) II, III, IV 
 
To obtain L-cells stably expressing nephrin, Neph1, Neph3 and EGFP alone or nephrin and 
Neph1 or Neph3 in combination, packaging cell lines were used for retrovirus production. 
293T cells were co-transfected with the retroviral constructs nephrin-pMSCVneo, Neph3-
EGFP-pMSCVpuro or EGFP-pMSCVpuro together with packaging vector pKAT (Finer et 
al., 1994). Alternatively, Phoenix Ampho packaging cells were transfected with retroviral 
constructs Neph1-HA-pBabe-hygro or pBabe-hygro. L-cells were infected with the 
retroviral supernatants and hygromycin, puromycin and G418 were used for selection of 
cells stably expressing nephrin, Neph1, Neph3 or EGFP. To generate stable cell lines 
expressing nephrin and Neph1 or Neph3 in combination, L-cells stably expressing nephrin 
were infected with retroviruses carrying Neph1-HA or Neph3-EGFP and selected with the 
appropriate antibiotic. 
3.3 Animals 
3.3.1 Nephrin-deficient mouse line (I)  
Nephrin TRAP mice were established in the GSF Centre for Environment and Health, 
Institute of Mammalian Genetics (Neuherberg, Germany), as described by Hill and Wurst 
(1993) and characterized by Rantanen et al. (2002). The localization and expression of 
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Neph1 and Neph3 were investigated in the kidneys of these mice. All experiments were 
approved by the Experimental Animal Committee of the University of Helsinki and the 
Provincial Government of Southern Finland. 
3.3.2 Sprague-Dawley rats (IV) 
The kidneys of Sprague-Dawley rats were used to investigate GABP? expression in the 
kidney. Animal work was approved by the national Animal Experiment Board. 
3.4 Antibodies (I-IV) 
The primary antibodies used in Studies I-IV are listed in Table 6. 
Table 6. Primary antibodies used in Studies I-IV. 
 
Antibody Description Reference / supplier Study 
Nephrin #033 (extracellular domain) rabbit polyclonal (Holthöfer et al., 1999) I 
Nephrin #1034 (intracellular domain) rabbit polyclonal (Ahola et al., 2003) I 
Nephrin pY1193 rabbit polyclonal (Jones et al., 2009) I 
Nephrin pY1217 rabbit polyclonal (Jones et al., 2009) I 
Neph1 rabbit polyclonal (Sellin et al., 2003) I 
Neph3 #1201 rabbit polyclonal (Ihalmo et al., 2007) I 
Neph3 rabbit polyclonal Alpha Diagnostic International 
(San Antonio, TX, USA) 
I 
Podocin rabbit polyclonal Sigma (St. Louis, MO, USA) I 
GFP rabbit polyclonal Invitrogen I 
HA mouse monoclonal Covance (Emeryville, CA, 
USA) 
I 
Myc mouse monoclonal Clontech Laboratories 
(Mountain View, CA, USA) 
I 
Phosphotyrosine mouse monoclonal Sigma I 
Tubulin mouse monoclonal Sigma I 
Actin mouse monoclonal Sigma I, IV 
Sp1 (H-225; sc-14027) rabbit polyclonal Santa Cruz Biotechnology 
(Santa Cruz, CA, USA) 
II 
NF-?B p50 rabbit polyclonal Abcam (Cambridge, UK) II, III 
NF-?B p65 rabbit polyclonal Abcam II, III 
WT1 (C-19; sc-192) rabbit polyclonal Santa Cruz III 
WT1 (6F-H2) mouse monoclonal Upstate (Lake Placid, NY, 
USA) 
unpublished 
data 
GABP? (G-1; sc-28312) mouse monoclonal Santa Cruz IV 
GABP? (H-180; sc-22810) rabbit polyclonal Santa Cruz IV 
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3.5 Cell assays 
3.5.1 Hanging drop aggregation assay (I) 
To investigate whether nephrin, Neph1 and Neph3 can promote cell adhesion, the adhesive 
properties of L-cells stably expressing nephrin, Neph1 and/or Neph3 were examined by 
hanging drop aggregation assay. Single cell suspensions of L-cells were placed in drops of 
culture medium on the lids of culture dishes. After incubation cells and cell aggregates in 
the hanging drop cultures were counted so that cell aggregate containing more than four 
cells was determined as a single particle. 
3.5.2 Reporter gene assay (II-IV) 
To investigate the regulatory regions and transcription factors important for nephrin and 
Neph3 gene regulation, A293 cells were transiently transfected with nephrin and Neph3 
luciferase reporter gene constructs together with Renilla luciferase reporter vector (phRL-
TK;  Promega,  Madison,  WI,  USA),  which  was  used  as  an  internal  control  to  correct  the  
transfection efficiency. Transcription factor overexpression studies were performed either 
in A293 cells (NF-?B, WT1 and GABP studies) or in Drosophila S2 cells (Sp1 studies). 
Expression vectors for transcription factors were co-transfected with reporter gene vectors 
(nephrin and Neph3 luciferase reporter gene construct and phRL-TK vector). A293 cells 
were lysed 24 h and Drosophila S2 cells 48 h after transfection, and luciferase activities 
were measured using the Dual-Luciferase Reporter Assay System (Promega). The studied 
luciferase activities (firefly luciferase) were normalized by control luciferase activities 
(Renilla luciferase) in A293 cells or by the protein concentration measured using a 
Bradford protein assay (Bio-Rad Laboratories, Hercules, CA, USA) in Drosophila S2 cells. 
3.5.3 Transcription factor overexpression studies (II, III) 
To investigate the effects of transcription factors on the expression of endogenous nephrin 
and Neph3 mRNA, A293 cells were transfected with expression vectors for transcription 
factors and RNA was extracted 48 h after transfections and studied by quantitative reverse 
transcription-PCR (qRT-PCR) as described in Section 3.9.3. 
3.5.4 TNF-?, BAY 11-7082 and 5-aza-2’-deoxycytidine treatments (III) 
To investigate the involvement of NF-?B in the regulation of nephrin and Neph3 genes, 
differentiated podocytes were treated with NF-?B activator TNF-? and NF-?B pathway 
inhibitor BAY 11-7082, and RNA was extracted for qRT-PCR. To determine whether DNA 
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methylation plays a role in regulating nephrin and Neph3 gene expression, A293 cells and 
undifferentiated and differentiated podocytes were treated with the demethylating agent, 5-
aza-2’-deoxycytidine, and RNA was studied by qRT-PCR. Treatments of the cell lines are 
explained in detail in Study III. 
3.6 Protein studies  
3.6.1 Preparation of E17 kidney lysates and glomerular and tubular lysates (I, 
IV) 
Mouse kidneys from nephrin-deficient and nephrin wild-type embryos at E17 were lysed 
using a glass homogenizer in RIPA lysis buffer containing 150 mM NaCl, 50 mM Tris-HCl 
(pH 8.0), 1% Nonidet P40, 0.5% sodium deoxycholate and 0.1% SDS supplemented with 
1? Complete, EDTA-free proteinase inhibitor cocktail (Roche, Mannheim, Germany). 
Glomeruli and tubules were isolated from rat kidney cortices using a graded sieving method 
(sieves of decreasing pore sizes: 250, 150 and 75 ?m) (Orlando et al., 2001). Tubules were 
collected from the 150-?m sieve and glomeruli from the final sieve, and both fractions were 
pelleted by centrifugation. Glomeruli and tubules were lysed in lysis buffer containing 150 
mM NaCl, 20 mM Tris-HCl (pH 7.5) and 1% Nonidet P-40, and supplemented with 1? 
Complete, EDTA-free proteinase inhibitor cocktail (Roche), 50 mM sodium fluoride and 1 
mM sodium orthovanadate by rotation at 4°C for 30 min. Insoluble material of the lysates 
was removed by centrifugation, and the protein concentrations were measured by using a 
Bradford assay. 
3.6.2 Preparation of total cell lysates (I, IV) 
Total lysates from L-cells were prepared using RIPA lysis buffer supplemented with 1? 
Complete, EDTA-free proteinase inhibitor cocktail (Roche). To obtain total cell lysates 
from A293 cells and undifferentiated and differentiated podocytes, cells were lysed into the 
buffer containing 150 mM NaCl, 20 mM Tris-HCl (pH 7.5) and 1% Nonidet P-40 
supplemented with 1? Complete, EDTA-free proteinase inhibitor cocktail (Roche), 50 mM 
sodium fluoride and 1 mM sodium orthovanadate. Cell lysates were rotated at 4°C for 30 
min, insoluble material was pelleted by centrifugation and protein concentrations were 
measured by using a Bradford assay. 
3.6.3 Preparation of nuclear extracts (IV) 
Nuclear extracts were prepared according to the protocol of Schreiber et al. (1989) from 
A293 cells and undifferentiated and differentiated podocytes. Cells were washed with PBS 
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and resuspended in buffer containing 10 mM HEPES (pH 7.9), 10 mM KCl, 0.1 mM 
EDTA, 0.1 mM EGTA and 1? Complete, EDTA-free proteinase inhibitor cocktail. Cells 
were allowed to swell on ice for 15 min, and thereafter, cell membranes were disrupted by 
adding Nonidet P-40. The resulting homogenate was centrifuged and the nuclear pellet was 
resuspended in buffer containing 20 mM HEPES (pH 7.9), 0.4 M NaCl, 1 mM EDTA, 1 
mM EGTA and 1? Complete, EDTA-free proteinase inhibitor cocktail, and rotated at 4°C 
for 15 min. The samples were centrifuged and supernatants containing the nuclear proteins 
were collected and their protein concentrations were measured by using a Bradford assay. 
3.6.4 Immunoblotting (I, III, IV) 
Proteins were separated by SDS-polyacrylamide gels, transferred to PVDF membranes 
(Millipore, Billerica, MA, USA), which were blocked with 5% skimmed milk or with 
Odyssey blocking buffer (LI-COR Biosciences, Bad Homburg, Germany). Membranes 
were incubated with specific primary antibodies and washed, and the bound antibodies 
were detected using secondary antibodies conjugated with fluorescent dyes Alexa Fluor 680 
(Invitrogen, Carlsbad, CA, USA) or IRDye 680 or 800 (LI-COR Biosciences). The signal 
was detected using the Odyssey infrared imaging system (LI-COR Biosciences). 
3.6.5 Immunofluorescence microscopy 
3.6.5.1 Immunofluorescence microscopy of kidney tissue (I, IV) 
Dissected kidneys from nephrin-deficient and nephrin wild-type embryos at E17 and from 
2-month-old Sprague-Dawley rats were snap-frozen in liquid nitrogen and further 
processed for cryosectioning. Tissue sections (6 ?m) were fixed with acetone, washed with 
PBS and blocked with  Cas  Block (Zymed Laboratories,  South  San Francisco,  CA,  USA) 
followed by overnight incubation with primary antibodies. Sections were washed with PBS 
and incubated with TRITC- or FITC-conjugated secondary antibodies and Hoechst 33342 
for nuclear staining, followed by washing with PBS and mounting with Mowiol. Sections 
were examined using an Olympus AX70 (Olympus, Tokyo, Japan) or Zeiss Axiophot 2 
microscope (Zeiss, Oberkochen, Germany). 
3.6.5.2 Immunofluorescence microscopy of cultured cells (I, III, IV) 
A293 cells, cultured podocytes and L-cells grown on glass coverslips were washed with 
PBS and fixed with PFA or acetone. L-cell hanging drop cultures were directly fixed with 
acetone. PFA-fixed cells were permeabilized with Triton X-100. Cells were then washed 
with PBS, blocked with the blocking solution (2% FBS, 2% BSA, 0.2% fish gelatine in 
PBS) or with CAS-block (Zymed Laboratories) and incubated with primary antibodies. 
After washing with PBS, cells were incubated with TRITC- or FITC-conjugated secondary 
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antibodies and Hoechst 33342 for nuclear staining, washed with PBS, mounted in Mowiol 
and examined using a Zeiss Axiophot 2 microscope (Zeiss). 
3.6.5.3 Surface staining (I) 
For surface staining of nephrin, L-cells grown on glass coverslips were incubated with an 
antibody directed against the extracellular domain of nephrin. After washes with PBS, 
stained cells were fixed with PFA, washed with PBS and blocked with 5% FBS, followed 
by incubation with TRITC-conjugated secondary antibodies, washes with PBS and 
mounting in Mowiol. Cells were viewed with a Leica TCS SP2 AOBS confocal microscope 
(Leica Microsystems GmbH, Wetzlar, Germany). 
3.6.6 Protein interaction studies 
3.6.6.1 Co-immunoprecipitation assay (I, III) 
A293 or 293T cells were transiently transfected with particular expression vectors and after 
48 h cells were lysed in 150 mM NaCl, 20 mM Tris-HCl (pH 7.5), 1% Nonidet P-40 
supplemented with 1? Complete, EDTA-free proteinase inhibitor cocktail (Roche), 50 mM 
sodium fluoride and 1 mM sodium orthovanadate. Insoluble material was removed by 
centrifugation and total protein concentration was measured by using a Bradford assay. Cell 
lysates were pre-cleared with protein A or G sepharose (Zymed Laboratories), followed by 
incubation overnight with primary antibodies or purified IgG serving as controls. Protein A 
or G sepharose was used to capture antibody-protein(s) complexes, and unbound proteins 
were removed by washing. For immunoprecipitations with intracellular fusion proteins 
(Study I), the preclearing step was omitted and cell lysates were incubated overnight with 
protein G sepharose, followed by washing steps. Finally, all samples were boiled in 
Laemmli sample buffer and immunoblotted. 
3.6.6.2 Pull-down assays with the extracellular domain of Neph3 (I) 
Signal plgplus vector containing the extracellular domain of Neph3 was transfected into 
293T cells, and after 48 h the Neph3 fusion protein was purified from the cell culture 
medium using protein A sepharose. Rat glomerular lysate was pre-cleared with protein A 
sepharose, followed by incubation with Neph3 fusion protein conjugated with protein A 
sepharose. Sepharose beads were washed and boiled in Laemmli sample buffer, and the 
samples were analysed by immunoblotting. 
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3.7 Computer-based promoter analysis 
3.7.1 Promoter alignment and identification of transcription factor binding 
sites (II-IV) 
Comparison of the nephrin and Neph3 promoter sequences between different species was 
performed using the alignment program DiAlign in the Genomatix software suite 
(www.genomatix.de). Putative binding sites for transcription factors in the nephrin and 
Neph3 promoter were identified using MatInspector software of Genomatix. The maximum 
core and matrix similarity is 1.0, and MatInspector considers a “good” match to the matrix 
to have similarity of > 0.80. The values of core and matrix similarities used to scan 
sequences for matches are reported in the Results section.  
3.7.2 Identification of Alu elements and CpG islands (II, III) 
Genomic repeats tool in Genomatix was used to localize Alu elements. To analyse the 
presence of CpG islands in the nephrin and Neph3 promoter, CpG Island Searcher 
(cpgislands.usc.edu/) and MethPrimer (www.urogene.org/methprimer/index1.html) were 
used.  
3.8 Chromatin immunoprecipitation (II-IV) 
To study the binding of transcription factors to the specific nephrin and Neph3 promoter 
regions, chromatin immunoprecipitation (ChIP) was performed with differentiated human 
podocytes using the ChIP-IT™ Express Kit (Active Motif, Carlsbad, CA, USA). 
Transcription factors were cross-linked to DNA by treating cells with 1% formaldehyde, 
after which cells were washed and the fixation reaction was terminated by adding glycine. 
Cells were collected and lysed, and thereafter, nuclei were pelleted and chromatin was 
shared by sonication into fragments of approximately 200-600 bp. For 
immunoprecipitations, shared chromatin was incubated overnight with specific antibodies 
or with IgG serving as a negative control. Immunocomplexes bound to protein G magnetic 
beads were collected and washed, the protein-DNA crosslinks were reversed and DNA was 
eluted for real-time PCR analysis performed in an iCycler system (Bio-Rad Laboratories). 
PCR reactions, primers and profiles are listed in the original publications II-IV. The 
specificity of the PCR products was verified by both melting curve analysis and agarose gel 
electrophoresis. 
46 
 
3.9 mRNA expression analysis 
3.9.1 RNA preparation (II, III) 
Total RNA was isolated from A293 cells and cultured podocytes with RNeasy Mini Kit 
(Qiagen, Hilden, Germany) according to the manufacturer’s protocol. RNA was treated 
with DNase I (Promega) and reverse-transcribed into cDNA (complementary DNA) using 
Primer random p(dN)6 (Roche) and M-MLV Reverse Transcriptase enzyme (Promega) as 
suggested in the manufacturer’s instructions. 
3.9.2 Conventional reverse transcription-PCR (II) 
Conventional reverse transcription-PCR (RT-PCR) was performed with HotStar Taq DNA 
polymerase (Qiagen). A detailed description of the PCR and primers can be found in Study 
II. PCR products were visualized on an agarose gel, and identity of the amplification 
products was confirmed by sequencing. 
3.9.3 Quantitative reverse transcription-PCR (II, III) 
Quantitative reverse transcription-PCR (qRT-PCR) was performed with an iCycler system 
(Bio-Rad Laboratories) using TaqMan gene expression assays (Applied Biosystems, Foster 
City, CA, USA) for human nephrin (Assay ID: Hs00190446_m1), Neph3 (Assay ID: 
Hs00375638_m1) and GAPDH (Hs99999905_m1) genes, and TaqMan Fast Universal PCR 
Master Mix (Applied Biosystems). The expression levels of nephrin and Neph3 mRNA 
were normalized against GAPDH using the comparative Ct (??Ct) method. 
3.10 Statistical analyses 
Statistical analyses were performed using Student’s t-test between two groups and using 
one-way ANOVA followed by the least significant difference (LSD) post hoc test for 
comparisons of several groups. P-values less than 0.05 were considered statistically 
significant. 
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4 RESULTS 
4.1 Neph3 is a component of the nephrin protein complex (I) 
Earlier studies have shown that Neph3 localizes to the SDs and shares high homology with 
other members of the Neph-protein family, Neph1 and Neph2 (Ihalmo et al., 2003; Sellin et 
al., 2003; Ihalmo et al., 2007). Neph1 and Neph2 interact with nephrin, and the 
extracellular domains of Neph1 and nephrin form homo- and heterodimers and these 
extracellular interactions are suggested to be involved in the formation of the SD (Barletta 
et al., 2003; Gerke et al., 2003; Liu et al., 2003; Gerke et al., 2005). We investigated 
whether Neph3 binds to nephrin and the nephrin protein complex and if so which parts of 
the proteins participate in the interactions. Co-immunoprecipitation assay using lysates 
from 293T cells overexpressing full-length nephrin and myc-tagged Neph3 revealed that 
nephrin and Neph3 interact with each other (Study I, Figure 1A). Pull-down assay using rat 
glomerular lysates and a fusion protein of the extracellular part of Neph3 showed that the 
extracellular domain of Neph3 mediates the interaction with nephrin (Study I, Figure 1B). 
Immunoprecipitation assays from 293T cells overexpressing full-length myc-tagged Neph3 
and the intracellular part of nephrin, Neph1 or Neph3 showed that the intracellular domains 
of nephrin, Neph1 and Neph3 participate in the interactions with Neph3 (Study I, Figure 
1C). These results establish that Neph3 homodimerizes and interacts with nephrin and 
Neph1, indicating that Neph3 is a component of the nephrin protein complex, and thus, 
may, similarly to nephrin and other Neph-family members, participate in the formation of 
the SD. 
4.2 Adhesive properties of nephrin, Neph1 and Neph3 (I) 
Since interactions between nephrin and Neph-family members are suggested to induce 
adhesion between neighbouring podocytes leading to the formation of the SD (Barletta et 
al., 2003; Gerke et al., 2003; Liu et al., 2003; Gerke et al., 2005), we used mouse L 
fibroblasts (L-cells) as a model to investigate the adhesion activity of nephrin, Neph1 and 
Neph3. For this purpose, we established stable L-cell lines expressing nephrin, EGFP-
tagged Neph3 or HA-tagged Neph1 alone or in combination and performed a hanging drop 
aggregation assay using these cell lines. The results revealed that nephrin alone does not 
induce cell adhesion, whereas Neph1 and Neph3 are able to induce cell adhesion alone, and 
further, the adhesion activity of Neph1 and Neph3 was enhanced when they trans-
interacted with nephrin. Cis-interactions between nephrin and Neph1 or Neph3 did not 
induce cell adhesion. A summary of the adhesion activities of nephrin, Neph1 and Neph3 in 
L-cells is presented in Figure 8. These results suggest that Neph1 and Neph3 are 
homophilic adhesion molecules and further indicate that trans-interactions of Neph1 and 
Neph3 with nephrin promote cell adhesion. 
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Figure 8. Summary of the adhesion activities of nephrin, Neph1 and Neph3 in L-cells stably 
expressing nephrin, Neph1 and/or Neph3. Homophilic interactions of nephrin or cis-
interactions between nephrin and Neph1 or Neph3 did not induce cell adhesion. Neph1 and 
Neph3 alone as well as their trans-interactions with nephrin induced cell adhesion (Study 
I). 
 
 
 
Tyrosine phosphorylation of nephrin mediates actin reorganization in podocytes (Jones et 
al., 2006; Verma et al., 2006; Zhu et al., 2008) and is increased during podocyte 
development and in experimental animal models showing podocyte injury and lack of 
proper SD structures (Li et al., 2004; Verma et al., 2006; Garg et al., 2007). We 
investigated whether cell adhesion induced by the trans-interaction of nephrin with Neph1 
or Neph3 alters the tyrosine phosphorylation status of nephrin. To this end, 
immunoprecipitation with nephrin antibody and quantitative immunoblot assay were 
performed from hanging drop cultures expressing nephrin only, cultures expressing nephrin 
and EGFP-tagged Neph3 or HA-tagged Neph1 in the same cell, or a combination of 
cultures expressing nephrin and EGFP-tagged Neph3 or HA-tagged Neph1 in different 
cells. The results showed that nephrin tyrosine phosphorylation stayed at similar levels in 
hanging drop cultures expressing nephrin and Neph1 or Neph3 in the same cell as in the 
culture expressing nephrin only. However, nephrin tyrosine phosphorylation decreased 
markedly in hanging drop cultures expressing nephrin and Neph1 or Neph3 in different 
cells relative to the culture expressing nephrin only (Study I, Figure 4A). The results further 
demonstrated that the decrease in nephrin phosphorylation occurs at sites other than 
Tyr1204 and Tyr1228 (rat sequence) (Study I, Figure 4E-F). The results indicate that the 
trans-interaction between nephrin and Neph1 or Neph3 inducing cell adhesion results in 
nephrin dephosphorylation. 
4.3 Neph3 is up-regulated in nephrin-deficient mouse kidneys 
(I) 
Mice lacking nephrin are born without typical SDs, but the podocyte foot processes of these 
mice are connected by narrow tight junction-like structures (Rantanen et al., 2002). Since 
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we found that Neph1 and Neph3 are homophilic adhesion molecules mediating cell-cell 
contact formation, the localization and expression of Neph1 and Neph3 in nephrin-deficient 
mouse kidneys were investigated. Quantitative immunoblotting analysis revealed a 
significant increase in Neph3 expression in nephrin-deficient mouse kidneys, whereas the 
increase in Neph1 expression did not reach statistical significance (Study I, Figure 5A-B). 
Immunofluorescence microscopy showed a similar expression pattern of Neph3 in nephrin-
deficient mouse kidney sections as in wild-type kidneys; Neph3 localized in the podocytes 
lining the capillary loops (Study I, Figure 5C). These results suggest that when nephrin is 
absent  Neph3  may  have  a  role  in  the  formation  of  tight  junction-like  structures  between  
podocytes. 
4.4 Characterization of the chromosomal region of Nephrin-
Neph3 gene pair 
4.4.1 Nephrin-Neph3 promoter sequence comparison between species 
The human nephrin and Neph3 genes, NPHS1 and KIRREL2, respectively, are located on 
chromosome 19q13.12 in a head-to-head orientation separated by a 4914-bp intergenic 
region. The mouse and rat nephrin and Neph3 genes have a similar head-to-head 
arrangement, but in mouse 7qB1 and rat 1q21 chromosomes, genes are separated by shorter 
intergenic regions, 2542 bp and 2811 bp, respectively. This kind of bidirectional 
arrangement is often conserved at least among mammals, and the gene products of many 
bidirectional gene pairs are functionally related to each other (Adachi and Lieber, 2002; 
Trinklein et al., 2004; Li et al., 2006). Using UCSC Genome Browser and NCBI Map 
Viewer, the chromosomal regions flanking the nephrin-Neph3 gene pair in humans, mice 
and rats were investigated. The analysis revealed that in all species at least some of the 
genes near the nephrin-Neph3 gene pair are the same, e.g. APLP1, PRODH2 and UPK1A. 
This suggests that not only the gene pair arrangement but also the whole chromosomal area 
may have been conserved throughout evolution. Sequences for the human, mouse and rat 
nephrin genes were from GenBank under accession numbers NM_004646, NM_019459 
and AF161715, respectively, and for the human and mouse Neph3 genes NM_199180 and 
NM_130867, respectively. For the rat Neph3 gene, GenBank listed only the predicted 
sequence (XM_002725604). Genomic promoter sequences were obtained from the UCSC 
Genome Browser. 
Genomatix alignment tool DiAlign was used to perform a comparison of the human, mouse 
and rat sequences covering the region between the first exons of nephrin and Neph3 genes. 
The comparison revealed that, excluding the primate-specific Alu repetition sequences in 
human sequence (see Section 4.4.2), there is a high degree of local sequence similarity 
among these species. The human sequence shared 42% and 46% nucleic acid identity with 
mouse and rat sequences, respectively. The rat sequence showed 83% identity to the mouse 
sequence. Similarities in promoter sequences suggest a conservation of important 
regulatory elements. Figure 9 shows the genomic arrangement of the human, mouse and rat 
nephrin and Neph3 genes and features in the intergenic region. Figure 10 shows the 
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alignment of the promoter regions considered interesting due to the presence of potential 
important regulatory elements; these are described in more detail in later sections of the 
results. 
The mouse nephrin sequence contains an alternatively used exon 1B which is expressed 
only  in  the  cerebellum.  The transcription  start  site  (TSS)  for  exon 1B is  located  1808 bp 
upstream of the TSS for exon 1A (Beltcheva et al., 2003). Mouse exon 1B region, starting 
from the TSS, was compared with the same region in humans and rats. The sequences in 
this area showed 69% and 64% nucleic acid similarities for humans compared with mice 
and rats, respectively, and 90% similarity for the rat compared with the mouse. Whether the 
same alternatively used exon is present also in human and rat sequences remains to be 
elucidated. 
 
 
 
 
Figure 9. Genomic arrangement of nephrin and Neph3 genes in humans (NPHS1 and 
KIRREL2, respectively) and in mice and rats (Nphs1 and Kirrel2). TSS indicates the 
transcription start site and ATG the position of the translation initiation site. First exons 
are marked with white boxes and 5’ untranslated regions with hatched boxes. The location 
of Alu elements related to the Neph3 TSS is shown. The CpG islands are indicated with 
blue lines under the human sequence; the position of the CpG island in Neph3 proximal 
promoter and coding region is shown related to the Neph3 TSS and the positions of the two 
others related to the nephrin TSS. Functional transcription factor binding sites are marked 
with red boxes and the dotted line shows regions (1-3) considered interesting due to the 
presence of potential important regulatory elements. The alignment of the sequences of 
these regions is shown in Figure 10. Numbers indicate the distance in base pairs from the 
major TSS. TSS, transcription start site. 
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Figure 10. Alignment of sequences of regions 1-3 in Figure 9. The number of “*” 
characters below the alignment reflects the degree of local similarity; the maximum 
similarity is 5 “*” characters. Capital letters denote aligned nucleic acids and lower-case 
letters are considered not to be aligned. Lines are introduced to align the regions of 
maximal homology. Functional binding sites for indicated transcription factors are marked 
with red and putative binding sites for indicated transcription factors with black or grey. 
The numbers in region 1 indicate the distance in base pairs from the Neph3 TSS and in 
regions 2 and 3 from the nephrin TSS. Grey letters indicate the 5’ untranslated and coding 
region. TSS, transcription start site. 
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4.4.2 Features of the upstream region of human Neph3 gene (II) 
In the human genome, the TSSs of the nephrin and Neph3 genes are separated by a 4914-
bp-long intergenic region. Several studies have investigated the regulatory region of the 
nephrin gene, and thus, we concentrated on the intergenic region of the nephrin and Neph3 
genes mainly characterizing the 5’ upstream region from the Neph3 TSS. Sequence analysis 
revealed that the Neph3 proximal promoter between -200 bp and the TSS is a highly GC-
rich region, with a GC content of 73.5%. The region close to the start of transcription was 
noted to be devoid of typical TATA and CAAT boxes, as often seen with GC-rich 
promoters. Two primate-specific Alu repetition sequences were localized in the region from 
-3021 to -2795 and from -2544 to -2317 bp upstream from the TSS using Genomic repeats 
tool in Genomatix (Figure 9; page 50). Alternative promoters or TSSs were not found for 
Neph3 in literature or database searches using the UCSC Genome Browser. 
4.5 NF-?B and Sp1 regulate basal level expression of Neph3 
gene (II) 
To determine the minimal promoter region required for the basal transcriptional activity of 
the human Neph3 gene, a series of Neph3 luciferase reporter gene constructs containing 
various fragments of the Neph3 promoter were used. The constructs covered nucleotides 
from -5070, -4543, -3877, -2260, -1072, -536, -366, -162, -105 and -57 to +48 related to the 
Neph3 TSS. The proximal promoter region starting from -105 was revealed to be the major 
activation region for the Neph3 gene in A293 cells and the regulatory elements important 
for the constitutive transcriptional activity of the Neph3 gene were mainly located in the 
region between nucleotides -105 and -58 (Figure 11). Results also revealed the possible 
presence of a weaker activation site in the distal promoter region from -5070 to -3878, 
whereas repressing transcription factor binding sites may be present in the regions from      
-3877 to -2261 and from -162 to -106. Two Alu elements found in the human sequence 
were located within the region -3877/-2261, which may also be the reason for lower 
promoter activity. 
To define the transcription factors responsible for Neph3 promoter activity, the Neph3 
promoter region between nucleotides -105 and -58 was investigated in more detail. The 
sequence comparison between humans, mice and rats revealed a high degree of similarity 
(Figure 10, region 1; page 51). The location of transcription factor binding sites within this 
region in the human sequence was predicted by MatInspector software, and putative 
binding sites for NF-?B and Sp1 were found at positions -85 to -74 (core/matrix similarity: 
1.000/0.886) and -66 to -52 (1.000/0.930), respectively (Figure 10, region 1; page 51). 
According to site-directed mutations of the NF-?B and Sp1 binding sites, both response 
elements are essential for basal level activity of the Neph3 -105 promoter in A293 cells 
(Study II, Figure 3C). Furthermore, both transcription factors bound in a ChIP to the Neph3 
promoter region harbouring their respective binding sites (Study II, Figure 7). 
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Figure 11. Transcriptional activity of the 5’-flanking regions of the human Neph3 gene in 
A293 cells. The values represent means ±SD of one experiment performed in triplicate. The 
significance between the samples indicated by brackets is shown (**P < 0.01,               
***P < 0.001). LUC, luciferase gene (Study II and III). 
 
 
 
The role of NF-?B in Neph3 gene regulation was further analyzed and NF-?B p65 
overexpression was found to increase Neph3 mRNA level, and simultaneous 
overexpression of p50 and p65 led to a further increase (Figure 12A; page 55). This 
suggested that NF-?B functions as a p50/p65 heterodimer in Neph3 gene regulation. 
Reporter gene assay revealed that the activity of the Neph3 -105 promoter region is 
increased by p65 overexpression, but simultaneous overexpression of p50 and p65 subunits 
did not lead to a further increase (Figure 12B; page 55). However, the longer Neph3 
promoter region, -162, reached higher promoter activity by simultaneous p50 and p65 
overexpression than by p65 overexpression alone (Figure 12B; page 55). This supports NF-
?B acting as a p50/p65 heterodimer in regulating the Neph3 gene. The results also suggests 
that the region between nucleotides -162 and -106 may harbour additional functional NF-
?B binding sites or other sequences needed for optimal binding and function of NF-?B as a 
p50/p65 heterodimer. A search with MatInspector revealed several potential binding sites 
for NF-?B within the region from -162 to -106. According to the core and matrix similarity 
values, the two best matches occupy the same nucleotides at positions -129 to -115 
(1/0.877) and -131 to -117 (1/0.917). These sites are located in the region thought not to be 
conserved (lower-case letters in Figure 10, region 1; page 51), but a lack of conservation 
does not guarantee that the sites are not functional (Henikoff, 2007; Odom et al., 2007). By 
decreasing the core and matrix similarities, putative binding sites for NF-?B were found 
also in the conserved regions, with the site with the highest core and matrix similarity 
values located at position -147 to -133 (0.75/0.805) (Figure 10, region 1; page 51). 
Neph3 mRNA level was not increased by Sp1 overexpression in assays performed in A293 
cells, probably due to a high endogenous level of Sp1 in this cell type. However, reporter 
gene assay performed in Drosophila Schneider 2 (S2) cells, a cell model widely used in 
Sp1 studies due to their lack of endogenous Sp1, revealed that Sp1 overexpression activates 
the Neph3 -105 promoter (Study II, Figure 5). Further, when Sp1 binding site in the -105 
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construct was mutated, the activation by Sp1 was abolished, indicating that Sp1 activates 
Neph3 gene transcription through Sp1 binding site at position -66 to -52. 
4.6 WT1 and NF-?B synergistically activate nephrin and Neph3 
genes (III) 
Bidirectional gene pairs often have a shared promoter or common regulatory mechanisms 
that regulate both genes (Adachi and Lieber, 2002; Trinklein et al., 2004; Li et al., 2006). 
This prompted us to study whether nephrin and Neph3 genes share similar mechanisms in 
their transcriptional regulation. WT1 is a key regulator of podocyte function and it has 
previously been shown to activate transcription of the nephrin gene (Guo et al., 2004, 
Wagner et al., 2004). Thus, we hypothesized that WT1 might also regulate the Neph3 gene. 
Multiple putative binding sites for WT1 were found in at least partly conserved regions of 
the Neph3 promoter downstream and upstream from the functional NF-?B and Sp1 binding 
sites. According to the core and matrix similarity values, the best matches were located at 
positions -39 to -23 (1/0.930) and -144 to -128 (1/0.887) (Figure 10, region 1; page 51). 
WT1 was observed to occupy the Neph3 proximal promoter shown by a ChIP assay (Study 
III, Figure 4B), but luciferase reporter assay did not show an increase in Neph3 -162 
promoter activity with WT1 overexpression (Figure 12B). This led us to investigate 
whether WT1 collaborates with other transcription factor(s), and NF-?B was considered a 
candidate. Interestingly, Neph3 -162 promoter activity reached the highest level when WT1 
and NF-?B subunits p50 and p65 were overexpressed at the same time, suggesting co-
operativity between WT1 and NF-?B in the transcriptional regulation of the Neph3 gene 
(Figure 12B). Contrary to the reporter gene assay, WT1 overexpression up-regulated Neph3 
mRNA (Figure 12A), which might be explained by the artificial nature of promoter DNA in 
reporter constructs compared with the chromosomal structure of the endogenous gene. 
Synergism between WT1 and NF-?B was further supported by the finding that the NF-?B 
p50/p65 heterodimer co-operates with WT1 in up-regulating Neph3 mRNA expression 
(Figure 12A). 
In the search for common regulatory mechanisms for nephrin and Neph3 genes, potential 
co-operation of WT1 and NF-?B underlying also the regulation of the nephrin gene was 
investigated. Previous findings demonstrate that the functional WT1 binding site in the 
human nephrin promoter is located at position -654/-638 bp relative to the nephrin TSS 
(Guo et al., 2004). The use of MatInspector revealed several putative binding sites for NF-
?B (Figure 10, region 2; page 51). One putative binding site for NF-?B was located next to 
the WT1 site in a conserved area of the nephrin promoter, occupying nucleotides -636 to     
-622 (1/0.818). Another putative NF-?B binding site occupied nucleotides -581 to -567 
(1/0.838) and was located downstream of the WT1 site in a region whose sequence was not 
considered to be conserved in humans, mice and rats. By decreasing the core and matrix 
similarity values, more putative binding sites for NF-?B were found in the conserved 
regions downstream and upstream of the WT1 site. The best matches were located at 
positions -609 to -595 (0.75/0.747) and -758 to -744 (0.75/0.777). 
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Figure 12. Summary of the effect of NF-?B and WT1 overexpressions on Neph3 mRNA 
level (A) and promoter activity (B). (A) Data are presented relative to the control 
transfection (empty vector), and the values represent means and range of three 
measurements from two biological replicate experiments. (B) The results are presented as 
fold induction of the control experiment (empty vector), and the values represents means 
±SD from three independent experiments performed in triplicate. The significance relative 
to the control transfection or between the samples indicated by brackets is shown        
(***P < 0.001). LUC, luciferase gene (Studies II and III). 
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By a ChIP assay, WT1 and NF-?B p50 and p65 were shown to bind to the respective region 
of their putative binding sites in the nephrin promoter (Study III, Figure 4A). 
Overexpression of WT1 and NF-?B followed by analysis of nephrin mRNA level revealed 
that NF-?B p50 up-regulates nephrin mRNA expression and functions synergistically with 
WT1 (Figure 13A). Reporter gene assay of the nephrin -837 promoter also showed a 
synergistic effect of WT1 and p50, but also of p50 and p65. Individual p65 overexpression 
had no effect on nephrin promoter activity (Figure 13B), however, it did cause a massive 
increse in nephrin mRNA level (Figure 13A). These results suggest that WT1, p50 and p65 
are involved in nephrin gene regulation, but it is difficult to determine whether p65 co-
operates together with p50 and WT1. The nephrin promoter region may have multiple 
functional binding sites for NF-?B since in reporter gene assay, NF-?B overexpression 
induced also shorter fragment of the nephrin promoter (nephrin -617 promoter; Figure 
13B). 
Collectively, these results indicate that WT1 and NF-?B co-operatively regulate nephrin 
and Neph3 genes, which is further supported by an interaction between WT1 and NF-?B 
p65 as revealed by co-immunoprecipitation (Study III, Figure 5). 
4.7 TNF-? induces nephrin and Neph3 mRNA expression via 
the NF-?B pathway (III) 
NF-?B is an inducible transcription factor that is activated and translocated into the nucleus 
as a result of phosphorylation, ubiquitination and degradation of the cytoplasmic inhibitor 
??B-? bound to NF-?B (reviewed by Hayden and Ghosh, 2008). The involvement of NF-?B 
in the transcriptional regulation of nephrin and Neph3 genes prompted us to investigate the 
pathway leading to NF-?B-dependent nephrin and Neph3 gene expression. Previous 
findings have demonstrated that NF-?B activator TNF-? induces nephrin mRNA expression 
in human embryonic kidney cells (Huwiler et al., 2003). We took advantage of cultured 
human podocytes and treated them with TNF-? and further with the NF-?B pathway 
inhibitor BAY 11-7082, an inhibitor of cytokine-induced I?B-? phosphorylation, to 
confirm the involvement of NF-?B activation after TNF-? induction. Both nephrin and 
Neph3 mRNA expression was induced in response to TNF-?; nephrin mRNA expression 
was induced time- and dose-dependently (Figure 14A, page 58), and for Neph3, time- and 
dose-dependent responses were observed, but the responses were not statistical significant. 
Treatment with BAY 11-7082 attenuated TNF-? -induced nephrin and Neph3 mRNA 
expression (Figures 14B-C, page 58), indicating that NF-?B activation mediates the effect 
of TNF-?. Immunofluorescence stainings with NF-?B p65 antibody showed that TNF-? 
induced nuclear translocation of NF-?B and BAY 11-7082 inhibited this translocation, 
confirming that NF-?B is indeed inhibited (Study III, Figure 2E). Collectively, the results 
demonstrate that in cultured human podocytes NF-?B regulates nephrin and Neph3 mRNA 
in response to TNF-?. 
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Figure 13. Summary of the effect of NF-?B and WT1 overexpressions on nephrin mRNA 
level (A) and promoter activity (B). (A) Data are presented relative to the control 
transfection (empty vector), and the values represent means and range of three 
measurements from two biological replicate experiments. (B) The results are presented as 
fold induction of the control experiment (empty vector), and the values represents means 
±SD from three independent experiments performed in triplicate. The significance relative 
to the control transfection or between the samples indicated by brackets is shown        
(***P < 0.001). LUC, luciferase gene (Study III). 
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Figure 14. (A-C) TNF-? induces the expression of endogenous nephrin and Neph3 mRNA 
in podocytes via the NF-?B pathway. Data are presented relative to the cells treated with 
solvent only, and the values represent means and range of three measurements from two 
biological replicate experiments. The significance relative to the control transfection or 
between the samples indicated by brackets is shown (*P <0.05, **P < 0.01, ***P < 0.001) 
(Study III). 
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4.8 DNA methylation plays a role in regulating nephrin and 
Neph3 genes (III) 
Characterization of the Neph3 promoter revealed a highly GC-rich region in the Neph3 
proximal promoter (Section 4.4.2). In GC-rich regions, clusters of CpG dinucleotides are 
called CpG islands, and they represent an important feature of mammalian genomes. 
Methylation of CpG islands is involved in the regulation of transcription by leading to 
silencing of the associated gene (Siegfried et al., 1999; Strathdee et al., 2004). Interestingly, 
bidirectional gene pairs feature a significant enrichment of CpG islands, and their 
hypermethylation has been shown to silence the expression of both genes simultaneously 
(Adachi and Lieber, 2002; Trinklein et al., 2004; Shu et al., 2006). The presence of CpG 
islands in the intergenic region between the nephrin and Neph3 genes and in the coding 
regions of the nephrin and Neph3 genes was sought using two different CpG island 
searcher programs. The search criteria for a CpG island were defined as at least 50% GC 
content and an observed/expected CpG ratio greater than 0.6. CpG Island Searcher 
identified one CpG island covering the Neph3 proximal promoter and coding region 
between nucleotides -765 and +293, one CpG island closer to the nephrin TSS at position   
-1362/-1155 related to the nephrin TSS and one CpG island in the nephrin coding region at 
position +549/+720. MethPrimer program identified two CpG islands at similar locations in 
the nephrin promoter and coding region, at positions -1323/-1221 and +598/+702. The 
location of CpG islands in the human sequence is shown in Figure 9 (page 50). 
The presence of CpG islands in the regulatory regions of nephrin and Neph3 genes suggests 
that DNA methylation could play a role in regulating these genes. To investigate this, 
different types of cells, undifferentiated and differentiated podocytes and A293 cells, were 
treated with demethylating agent 5-aza-2’-deoxycytidine (5-azadC). In undifferentiated 
podocytes, which do not express nephrin or Neph3 mRNA at the basal level, the treatment 
resulted in dose-dependent increase in the mRNA expression of both nephrin and Neph3 
(Figure 15A). In differentiated podocytes (Figure 15B) and A293 cells (Figure 15C), both 
expressing nephrin and Neph3 mRNA endogenously, the treatment led to at least a partly 
dose-dependent up-regulation of nephrin and Neph3 mRNA. In A293 cells, however, the 
effect of 5-azadC was much stronger than in differentiated podocytes, an in vitro cell model 
currently considered the best for podocyte studies. Collectively, these data indicate that 
silencing by DNA methylation plays a similar role in nephrin and Neph3 gene regulation 
depending on the cell type and the differentiation stage of podocytes. DNA methylation 
may be involved in the regulation of tissue-specific expression of nephrin and Neph3 genes. 
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Figure 15. (A-C) Effect of demethylating agent 5-aza-2?-deoxycytidine (5-azadC) on 
endogenous nephrin and Neph3 mRNA in undifferentiated and differentiated podocytes and 
A293 cells. Data are presented relative to the cells treated with solvent only, and the values 
represent means and range of three measurements from two biological replicate 
experiments. The significance relative to the control transfection or between the samples 
indicated by brackets is shown (*P <0.05, **P < 0.01, ***P < 0.001) (Study III). 
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4.9 GABP regulates nephrin gene (IV) 
Transcription factor GA-binding protein (GABP) is suggested to be involved in regulating 
the cell-cell and cell-matrix interactions in, for example, leukocytes and myeloid cells 
(Bottinger et al., 1994; Rosen et al., 1994; Nickel et al., 1995; Rosmarin et al., 1995; 
Nuchprayoon et al., 1997) as well as in the formation and function of neuromuscular 
junctions (Fromm and Burden, 1998; Khurana et al., 1999; Mejat et al., 2003). These 
studies prompted our interest in analysing the role of GABP in podocytes and in nephrin 
gene regulation. Since previous findings demonstrate that GABP is expressed in the adult 
mouse kidney at the mRNA level (O'Leary et al., 2005), but a more precise expression 
pattern is unknown, immunofluorescence stainings of rat kidney sections and Western 
blotting of rat glomerular and tubular fractions were performed. Western blotting revealed 
that GABP is primarily expressed in glomeruli (Study IV, Figure 1E). Immunofluorescence 
stainings showed that GABP and WT1 co-localize in glomeruli, indicating expression of 
GABP in the podocyte nucleus (Figure 16). As expected due to the ubiquitous nature of 
GABP expression (reviewed by Rosmarin et al., 2004), GABP was also detected in cells 
other than podocytes, apparently mesangial cells. In A293 cells and cultured 
undifferentiated and differentiated human podocytes, GABP is highly enriched in the 
nucleus, as indicated by Western blotting and immunofluorescence staining (Study IV, 
Figures 2 and 3). 
 
 
Figure 16. Double staining of GABP? and WT1 indicates that GABP is expressed in 
podocyte nuclei in the rat kidney (Study IV). 
 
 
 
Because computation analysis revealed several putative binding sites for GABP distributed 
along the nephrin regulatory region, a series of deletion promoter fragments of nephrin 
(from nucleotides -837, -392, -48 and +25 to +156 related to the major nephrin TSS) in 
luciferase reporter vector were used to map the region where GABP might bind. Reporter 
gene assay with GABP? and GABP? overexpression revealed that GABP as a 
heterotetramer increases nephrin promoter activity (Study IV, Figure 4). Since the -48 
region was activated by GABP overexpression, the nephrin promoter region between the 
nucleotides -48 and +24 apparently harbours the functional element(s) for GABP. GABP 
binds to DNA sequences called Ets motifs (5’ GGAA 3’). Within the region -48/+24, 
MatInspector software revealed three putative GABP binding sites partially overlapping 
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and close to the TSS (named Ets(1), Ets(2) and Ets(3)) (Figure 10, region 3; page 51). 
These sites were found to be at least partly located in the conserved region, occupying 
nucleotides -13 to +8 (1/0.860), -5 to +16 (1/0.964) and +2 to +23 (1/0.920). A ChIP assay 
revealed that GABP binds to the region covering these three Ets sites (Study IV, Figure 6). 
According to site-directed mutations of the Ets binding sites, only Ets(1) site was essential 
for the basal level activity of the nephrin -48 promoter (Figure 17). However, GABP 
overexpression experiments with constructs harbouring mutated and non-mutated Ets 
binding sites showed that Ets(2) and Ets(3) mutations abolish the activation by GABP 
overexpression, confirming that at least these two sites are functional GABP binding sites 
(Figure 17). These results suggest that GABP is able to stimulate nephrin gene transcription 
through Ets sites located in the proximal nephrin promoter. 
 
 
 
Figure 17. Effect of GABP overexpression on nephrin promoter activity. The results are 
presented as fold induction of the control experiment (empty vector), and the values 
represent means ±SD from three independent experiments performed in triplicate. The 
significance relative to the control transfection (empty vector) or between the samples 
indicated by brackets is shown with asterisks, and hashes show the significance relative to 
the non-mutated construct (*P < 0.05, *P < 0.01, ***P < 0.001, ###P < 0.001). LUC, 
luciferase gene (Study IV). 
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5 DISCUSSION 
 
In the original publications of this thesis, Neph3 was shown to be part of the nephrin 
protein complex and to have similar functions as nephrin and Neph1-2 in forming homo- 
and heterodimers to participate in cell adhesion. The work also established transcriptional 
mechanisms behind nephrin and Neph3 gene regulation in podocytes and revealed a role for 
transcription factors WT1, NF-?B and Sp1 and DNA methylation in regulating the 
transcriptional activity of nephrin and Neph3 genes. Finally, transcription factor GABP was 
located in podocytes and shown to participate in nephrin gene regulation. The significance 
of these findings as they relate to existing data as well as some methodological aspects will 
be discussed in the following sections. 
5.1 Neph3 shares similar functions with nephrin and Neph-
family members 
5.1.1 Neph3 is a component of the nephrin protein complex 
Neph3, similarly to nephrin and the two other members of the Neph-protein family, Neph1 
and Neph2, localizes to the SD (Holthöfer et al., 1999; Holzman et al., 1999; Ruotsalainen 
et al., 1999; Barletta et al., 2003; Liu et al., 2003; Gerke et al., 2005; Ihalmo et al., 2007). 
The existing data demonstrate that nephrin, Neph1 and Neph2 are present in the same 
protein complex (Barletta et al., 2003; Gerke et al., 2003; Liu et al., 2003; Gerke et al., 
2005) and interact with the SD proteins podocin and ZO-1 (Huber et al., 2001; Huber et al., 
2003b; Sellin et al., 2003; Lehtonen et al., 2004). Since Neph3 has also been shown to 
interact with podocin and ZO-1 (Huber et al., 2003b; Sellin et al., 2003), it was speculated 
to be a component of the nephrin protein complex. We showed that Neph3 interacts with 
nephrin and Neph1, and similarly to nephrin, Neph1 and Neph2 (Gerke et al., 2003; 
Khoshnoodi et al., 2003; Gerke et al., 2005), it forms homodimers (Study I). Thus, Neph3 
belongs to the nephrin protein complex and most probably shares similar functions and 
behaviour with nephrin and Neph-family members and participates in the formation of the 
SD. 
5.1.2 Nephrin, Neph1 and Neph3 in cell adhesion 
Nephrin and Neph-family members are suggested to play a key role through their 
interactions in cell adhesion between neighbouring podocytes. In Drosophila and C. 
elegans, the interactions between nephrin and Neph1-3 orthologues that occur between 
opposing cell surfaces promote cell adhesion during muscle, eye and synapse development 
(Bour et al., 2000; Ruiz-Gomez et al., 2000; Dworak et al., 2001; Strunkelnberg et al., 
2001; Shen and Bargmann, 2003; Shen et al., 2004; Bao and Cagan, 2005). We revealed in 
Study I that both Neph1 and Neph3 induce cell adhesion in a homophilic fashion, whereas 
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nephrin does not. To form cell-cell contacts, nephrin was shown to require co-operativity 
with Neph1 or Neph3. However, cell-cell contacts were formed only when nephrin and 
Neph1 or Neph3 interacted in trans on the opposite cell surfaces. Cis-interactions of 
nephrin and Neph1 or Neph3 in the same cell were unable to induce cell adhesion but rather 
inhibited the adhesion activity. If nephrin, Neph1 and Neph3 are all expressed in podocytes 
and localize in the SD, why does the presence of nephrin and Neph1/Neph3 in the same cell 
then inhibit the adhesion activity? Possibly, the intracellular interactions between nephrin 
and Neph1/Neph3 enhance structural and/or functional changes in the extracellular binding 
domains of Neph1 and Neph3, thus blocking their interactions. Further, mouse L fibroblasts 
(L-cells) used in these adhesion assays represent a simple cell culture model and may lack 
important molecules, such as certain SD components, or signalling pathways needed for 
proper behaviour of nephrin and Neph-family members. 
L-cells, generally, do not form intercellular connections due to lack of endogenous 
expression of adherens junction proteins like cadherins. L-cells have therefore been widely 
used in studies related to adhesion and attachment; for example, in evaluating adhesion 
activity of some Ig superfamily proteins such as nectins (Satoh-Horikawa et al., 2000). L-
cells are a relevant in vitro model also for our purposes. However, the use of different cell 
models and techniques in adhesion assays may produce discrepant results. Our findings 
demonstrated that nephrin is unable to induce cell adhesion in a homophilic fashion, but 
others have using adherent HEK293 cells shown that nephrin expression induces formation 
of cell aggregates (Khoshnoodi et al., 2003). These results suggest that nephrin alone 
cannot promote cell adhesion in adhesion-deficient cells, but in adherent cells expressing 
proteins that most probably contribute to cell-cell contact formation, nephrin induces cell 
adhesion. In terms of nephrin-Neph3 interaction, we demonstrated that nephrin and Neph3 
induce cell adhesion via their heterophilic trans-interactions, whereas Nishida et al. (2010) 
did not observe the same effect in Jurkat cells, which are T-lymphocytes.  
5.1.3 Relationship between nephrin-Neph1/Neph3 interaction and nephrin 
phosphorylation 
Nephrin is a signalling molecule and through the tyrosine phosphorylation of its 
intracellular domain nephrin induces signalling cascades that lead to actin polymerization 
(Jones et al., 2006; Verma et al., 2006; Zhu et al., 2008), elevated cytosolic calcium levels 
(Harita et al., 2009) and raft-mediated endocytosis of nephrin (Qin et al., 2009). An 
increase in nephrin phosphorylation is detected during podocyte development as well as in 
experimental animal models, such as passive Heymann nephritis, protamine sulphate 
nephrosis and puromycin aminonucleoside-induced nephrosis, all of which show podocyte 
injury and a lack of proper SD structures (Li et al.,  2004; Verma et al.,  2006; Garg et al.,  
2007). During podocyte foot process development and podocyte injury, podocytes undergo 
morphological alterations suggested to be linked to, for example, changes in podocyte actin 
cytoskeleton structure via actin polymerization. Once the SD is formed, less nephrin 
signalling  is  speculated  to  be  needed to  regulate  actin  cytoskeleton.  In  line  with  this,  our  
data showed that nephrin tyrosine phosphorylation decreases when cell-cell contacts were 
formed through nephrin and Neph1/Neph3 trans-interactions (Study I). As mentioned, 
nephrin phosphorylation is increased during podocyte development and in experimental 
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animal models of podocyte injury (Li et al., 2004; Verma et al., 2006; Garg et al., 2007). 
However, nephrin is phosphorylated also in mature podocytes (Jones et al., 2009), and a 
decrease in nephrin phosphorylation is detected in patients with minimal change nephrosis 
and in rats with puromycin aminonucleoside-induced nephrosis (Uchida et al., 2008). Thus, 
nephrin phosphorylation and de-phosphorylation occurring at multiple sites in the nephrin 
intracellular domain and the balance between the phosphorylated and dephosphorylated 
stages  appear  to  be  important  factors  in  maintaining  the  integrity  of  the  SD  as  well  as  
podocyte morphology and function. 
5.2 Lack of nephrin leads to up-regulation of Neph3 
In mice lacking nephrin, podocyte foot processes are not connected to the SD, but the 
filtration slits are narrowed and connected by tight junction-like structures and show up-
regulation of tight junction protein claudin-3 (Rantanen et al., 2002; Done et al., 2008). We 
established that Neph3 expression is up-regulated in nephrin-deficient kidneys; the 
expression of Neph1 was also increased, but did not reach statistical significance (Study I). 
Even though Neph3 is structurally related to nephrin, apparently it and its up-regulation in 
the absence of nephrin cannot compensate for the function of nephrin in the SD formation. 
Neph1 and Neph3 were shown to be homophilic adhesion molecules and to mediate cell-
cell contact formation (Study I). Thus, in the absence of nephrin, Neph1/Neph3 might 
participate in the formation of tight junction-like structures present in nephrin-deficient 
mice. Notably, the extracellular domains of Neph1/Neph3 are shorter than that of nephrin, 
which could explain the formation of a narrower junction than the SD (Ihalmo et al., 2003; 
Sellin et al., 2003). 
During glomerular development in zebrafish, Neph3 expression peaks in developing 
podocytes, but is then down-regulated upon glomerular maturation (Wang et al., 2012). 
Similarly, in the developing spinal cord of the mouse, Neph3 is first up-regulated in the 
post-mitotic neural precursor cells, but becomes down-regulated during maturation of 
neurons (Minaki et al., 2005). The expression of Neph3 in developing and mature 
podocytes in the mouse is not known. However, podocytes arise from tight junctions 
(Reeves et al., 1978) and the loss of podocyte foot process architecture and the appearance 
of tight junctions in nephrin-deficient mice indicate that podocytes regress to more 
primitive developmental stages. Since Neph3 is up-regulated in these mice, it could be that 
similar down-regulation of Neph3 as observed in zebrafish glomeruli and mouse neurons 
during maturation also occurs in mouse podocytes. 
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5.3 Nephrin and Neph3 genes are regulated by common 
mechanisms 
5.3.1 Bidirectional arrangement of nephrin and Neph3 genes 
The human nephrin and Neph3 genes, NPHS1 and KIRREL2, reside on chromosome 
19q13.12, where the TSSs of the genes are separated by a 4914-bp intergenic region and the 
genes are transcribed into opposite directions. The mouse and rat nephrin and Neph3 genes 
have a similar head-to-head (bidirectional) arrangement, but in mouse 7qB1 and rat 1q21 
chromosomes, the genes are separated by shorter intergenic regions, 2542-bp and 2811-bp, 
respectively. We compared the intergenic regions of the nephrin-Neph3 gene pair among 
humans, mice and rats and found that, excluding the additional approximately 2-kb region 
in the human sequence, the sequences are highly conserved. The additional region in the 
human sequence was found to contain Alu elements, which are primate-specific repetitive 
DNA elements. Alu elements have potential regulatory functions and have been shown to 
contribute actively to primate evolution (reviewed by Hasler and Strub, 2006). The 
presence of Alu elements may explain the difference in the length of the intergenic regions 
of the nephrin-Neph3 gene pair between humans and rodents.  
Human chromosome 19 and related regions in the mouse show conservation of general 
gene arrangement (Dehal et al., 2001; Grimwood et al., 2004). In line with this we revealed 
that the chromosomal regions flanking the nephrin-Neph3 gene pair in humans and mice as 
well  as  in  rats  contain  the  same  genes.  Human  chromosome  19  is  the  most  gene-dense  
human chromosome (Venter et al., 2001), and more than 25% of its genes belong to 
clustered gene families. A marked prevalence of two kinds of duplication events is present 
in chromosome 19: tandemly clustered gene families and large segmental duplications 
(Grimwood et al., 2004). Based on this and conservation of the bidirectional arrangement as 
well  as  the  flanking  regions  of  nephrin  and  Neph3  genes,  it  may  be  that  not  only  the  
nephrin-Neph3 gene pair but the whole chromosomal area flanking it has been conserved 
throughout evolution and has evolved through chromosomal rearrangement or duplication. 
Bidirectional arrangement of genes is a relatively common feature of the genome and is 
often conserved among mammals, suggesting an important biological function. Despite 
substantial interest in bidirectional gene pairs, their transcriptional regulatory mechanisms 
remain poorly understood. Many bidirectional gene pairs, e.g. SERPINI1-PDCD10 and 
PREPL-C2ORF34 gene pairs, share regulatory elements that control both genes (Chen et 
al., 2007; Huang and Chang, 2009). Bidirectional gene pairs typically demonstrate an 
overlapping, but not identical, expression pattern in different cell and tissue types. 
Bidirectional gene pairs coding for homologous proteins, like nephrin and Neph3, are 
uncommon. Instead, the gene products of bidirectional gene pairs are often functionally 
related to each other or they operate in the same biological pathway for which the shared 
regulatory region(s) provide coordinated temporal and spatial expression (Adachi and 
Lieber, 2002; Trinklein et al., 2004; Li et al., 2006). Computational genome-wide analysis 
has demonstrated that more than 10% of the human genes represent bidirectionally 
arranged gene pairs whose TSSs are separated by less than 1000-bp (Trinklein et al., 2004). 
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However, the optimal length of a bidirectional promoter is not known. For example, it has 
been reported that a bidirectional gene pair with even a 25-kb intergenic region shows 
simultaneous induction of both genes through common regulatory elements (Ueda et al., 
2006). Other features describing bidirectional gene pairs include lack of TATA boxes and 
the presence of GC-rich promoters. Nephrin and Neph3 have all of the features suggested 
for bidirectional gene pairs, and it is therefore likely that nephrin and Neph3 genes share 
key features in their regulation. 
5.3.2 WT1, NF-?B and Sp1 in the regulation of nephrin and Neph3 genes 
The genomic arrangement of nephrin and Neph3 genes and the high degree of similarity in 
their promoter sequences among humans, mice and rats indicate conservation of important 
regulatory elements and common regulatory mechanisms for nephrin and Neph3 genes. 
WT1 is an important transcription factor in nephrin gene expression (Guo et al., 2004; 
Wagner et al., 2004), but several different transcription factors apparently participate in the 
constitutive regulation of the nephrin gene in podocytes. A 1.25-kb region of the human 
nephrin proximal promoter is essential for the podocyte-specific expression of nephrin 
(Wong et al., 2000), and within this region, a highly conserved 186-bp fragment, which 
contains a functional binding site for WT1, alone drives the expression in podocytes (Guo 
et al., 2004). However, some of the transgenic lines generated with this 186-bp fragment 
showed mosaic and ectopic expression of the nephrin promoter-driven lacZ gene. This 
suggests that, in addition to WT1, other factors binding to the elements outside this 
fragment are needed for the proper spatial and temporal expression of nephrin in podocytes. 
To support this hypothesis, we demonstrated that NF-?B is involved in the regulation of the 
human nephrin gene (Study III). Transcription factor Sp1 is suggested to have a role in 
nephrin gene regulation in mice (Beltcheva et al., 2010). Since the Sp1 binding region was 
highly conserved in mice and humans, it is possible that Sp1 also interacts with the human 
sequence.  
The transcriptional regulation of the Neph3 gene in podocytes had not been studied prior to 
this work. We found that the main activating regulatory region of the Neph3 gene is located 
in its proximal promoter and that transcription factors NF-?B and Sp1 are involved in the 
constitutive expression of the Neph3 gene in podocytes (Study II). Study III added WT1 to 
the group of Neph3 gene regulators. Collectively, the same transcription factors participate 
in the regulation of both Neph3 and nephrin genes. It is a common phenomenon that 
transcription factors regulate transcription through protein-protein interactions and co-
operation with other transcription factors. Thus, it was tempting to speculate that 
transcription factors WT1, NF-?B and Sp1 may work together via their interactions in the 
regulation of nephrin and Neph3 genes. Study III indeed showed that WT1 and NF-?B 
physically interact and co-operatively regulate both nephrin and Neph3 genes. Others have 
reported an interaction between Sp1 and NF-?B as well as their co-operative function in, 
for example, HIV-1 enhancer activation (Perkins et al., 1993; Perkins et al., 1994; Sif and 
Gilmore, 1994). We could not reliably test the co-operativity between NF-?B and Sp1 in 
the regulation of nephrin and Neph3 genes due to cell line-specific issues. A293 cells are a 
relevant model for most of the studies investigating the transcriptional regulation of nephrin 
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and Neph3 genes. However, A293 cells, like most mammalian cell lines, express Sp1 
endogenously at very high level and therefore, Sp1 overexpression studies were not feasible 
with these cells. For the same reason, the co-operative function of WT1 and Sp1, or NF-?B, 
WT1 and Sp1 in the regulation of nephrin and Neph3 genes remains unclear. 
Transcription factors can mediate their transactivation effects either directly by binding to 
their response elements in the promoter or indirectly via other transcription factors. Study II 
showed that NF-?B and Sp1 mediate their effects on the Neph3 gene through their binding 
sites located in close proximity to each other in the Neph3 proximal promoter. We, 
however, noted that possibly additional functional NF-?B binding sites may be located just 
upstream  from  the  functional  NF-?B  and  Sp1  elements.  In  the  Neph3  promoter,  we  
identified one putative binding site for WT1 downstream and one upstream from the 
functional NF-?B and Sp1 binding sites. Since the functionality of the WT1 binding sites 
was not tested, it remains uncertain whether the effect of WT1 on Neph3 gene regulation is 
direct or indirect. Human nephrin proximal promoter harbours the functional WT1 binding 
site (Guo et al., 2004). We detected several putative binding sites for NF-?B both upstream 
and downstream of this WT1 element, and our results suggest that there are most probably 
multiple functional NF-?B binding sites in the nephrin promoter (Study III). However, their 
functionality remains to be clarified, and moreover, an indirect effect of NF-?B via WT1 on 
the nephrin promoter is also possible.  
Taken together, human nephrin and Neph3 genes are both regulated by transcription factors 
WT1  and  NF-?B,  and  the  Neph3  gene  also  by  Sp1.  At  least  partly,  these  transcription  
factors interact with each other and function co-operatively in the regulatory processes of 
nephrin and Neph3 genes. There might be multiple functional binding sites for WT1 in the 
Neph3 promoter and for NF-?B in both nephrin and Neph3 promoters. WT1 and NF-?B 
can also indirectly participate in the regulation of the Neph3 and nephrin genes, 
respectively. The results suggest that there are two or more separate regulatory regions for 
nephrin and Neph3 genes, and it may be that these regulatory regions form a common 
transactivation complex through looping of the DNA (Figure 18). 
 
 
 
Figure 18. Schematic illustration of the studied transcription factors regulating human 
nephrin (NPHS1) and Neph3 (KIRREL2) genes. Functional response elements are boxed 
and putative response elements are shown with a dotted box and a question mark. The 
numbers below the functional response elements indicate the position related to 
nephrin/Neph3 TSS. RE, response element; TSS, transcription start site. 
69 
 
5.3.3 Role of different NF-?B subunits in regulation of nephrin and Neph3 
genes 
The NF-?B family consists of five members that normally exist as homo- and heterodimers. 
All of them are reported to be present in podocytes, and p65 homodimer and p50/p65 
heterodimer  are  the  most  abundant  dimers  in  the  regulatory  processes  of  many cell  types  
(Baldwin, 1996; Karin and Ben-Neriah, 2000; Mudge et al., 2001; Martinka and 
Bruggeman, 2006; Hussain et al., 2009). We showed that NF-?B functions as a p50/p65 
heterodimer in Neph3 gene regulation (Studies II and III). Study III further demonstrated 
that the p50/p65 heterodimer co-operates with WT1 in the regulation of the Neph3 gene. 
The precise role of p50 and p65 subunits in nephrin regulation remained somewhat 
ambiguous, as Study III revealed controversial results between experiments performed with 
promoter constructs and the endogenous gene. The reasons for the discrepancies may be 
due to the artificial nature of promoter DNA constructs versus the chromosomal structure of 
the endogenous gene. In addition, endogenous NF-?B may have had an effect on 
overexpressed subunits. Thus, it is difficult to determine which homo- or heterodimer(s) of 
the p50 and p65 subunits are involved in nephrin gene regulation and further co-operate 
with WT1. It is likely, however, that different NF-?B homo- and heterodimers regulate and 
co-operate with other transcription factors in different ways under various 
(patho)physiological conditions. 
5.3.4 TNF-? and NF-?B pathway in regulating nephrin and Neph3 genes 
NF-?B is an inducible transcription factor whose activation is associated with multiple 
stimuli and responses, and it is known to be rapidly activated and translocated into the 
nucleus by, for example, cytokines (reviewed by Hayden and Ghosh, 2008). TNF-? has 
been demonstrated to up-regulate nephrin mRNA and protein expression in human A293 
kidney cells (Huwiler et al., 2003). In line with this, Study III revealed that TNF-? 
specifically activates NF-?B and increases nephrin mRNA level in cultured human 
podocytes. Similarly, Neph3 mRNA level was shown to be increased by TNF-?. In cultured 
mouse podocytes, TNF-? activates NF-?B, but, in contrast to human cells, TNF-? down-
regulates nephrin mRNA expression (Yamauchi et al., 2006; Saito et al., 2010). The 
discrepancy between human and mouse cell lines regarding nephrin expression may be 
explained by differences in cell models or differential regulation of nephrin by TNF-? in 
different species. 
NF-?B has been shown to be activated in podocytes in experimental kidney disease models 
(Mudge et al., 2001; Martinka and Bruggeman, 2006; Fujihara et al., 2007) and in the 
pathogenesis of various human kidney diseases, including diabetic nephropathy (DN) 
(Mezzano et al., 2004; Zheng et al., 2006). As cytokines, including TNF-?, are involved in 
the development and progression of DN (reviewed by Navarro-Gonzalez and Mora-
Fernandez, 2008), it is possible that also in DN the stimulus for NF-?B activation may 
originate from cytokines. Notably, in the kidneys of patients with DN, nephrin and Neph3 
mRNA show down-regulation (Toyoda et al., 2004; Ihalmo et al., 2007). However, the 
mRNA expression of nephrin in DN, seems to be complex since during the development of 
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DN in a rat model, nephrin mRNA expression changes dynamically, showing first 
increased expression and later down-regulation (Forbes et al., 2002). Further studies are 
needed to clarify the role of NF-?B regulating nephrin and Neph3 genes under 
pathophysiological conditions.  
The link between the nephrin/Neph3 gene and NF-?B is likely to be complex. The lack of 
functional nephrin in cultured human podocytes is associated with NF-?B activation 
(Hussain et al., 2009). This, together with our results showing up-regulation of the nephrin 
gene by NF-?B (Study III), suggests feedback regulation between nephrin and NF-?B. In 
mice in which NF-?B was activated by disruption of the natural NF-?B pathway inhibitor 
Par4, nephrin protein level showed down-regulation in podocytes (Hussain et al., 2009). 
Down-regulation was, however, consistent with podocyte injury and loss, therefore likely 
representing an end-stage finding and is not in conflict with our results. In conclusion, 
distinct (patho)physiological conditions may alter the expression or activity of NF-?B in 
podocytes, thereby contributing to the regulation of nephrin and Neph3 genes in different 
ways under various circumstances. 
5.3.5 Role of DNA methylation in regulation of nephrin and Neph3 genes 
DNA methylation represents an important mechanism of epigenetic regulation and is 
involved in the regulation of transcription. DNA methylation usually occurs in CpG islands, 
and in certain cells, most CpG islands are unmethylated, keeping the associated genes 
active. However, in various cell types, during development and differentiation and in some 
pathological situations, CpG islands are methylated, leading to silencing of the associated 
genes (Siegfried et al., 1999; Strathdee et al., 2004). One of the features observed in 
bidirectional gene pairs is the presence of CpG islands in their promoter region (Adachi and 
Lieber, 2002; Trinklein et al., 2004). In line with this, computer-based analysis detected 
three CpG islands within the intergenic region between nephrin and Neph3 genes and their 
coding regions (Studies II and III). 
Study III demonstrated that a treatment with a demethylating agent, 5-aza-2’-
deoxycytidine, of undifferentiated cultured human podocytes, which do not express nephrin 
or Neph3 mRNA endogenously, led to an increase in nephrin and Neph3 mRNA 
expression. In differentiated cultured human podocytes, an in vitro cell model currently 
considered the best for podocyte studies, the treatment increased only slightly the 
expression of nephrin and Neph3 mRNA. In the third tested cell line, A293, which 
represents non-podocyte cells but expresses nephrin and Neph3 mRNA endogenously, 
nephrin and Neph3 mRNA expressions were increased markedly by the demethylating 
agent treatment. The results suggest that silencing the transcription of nephrin and Neph3 
genes by DNA methylation depends on the cell type and the differentiation stage of 
podocytes and that nephrin and Neph3 genes behave similarly. Interestingly, 
hypermethylation of CpG islands associated with bidirectional gene pairs, e.g. WNT9A-
CD558500 gene pair, can silence the expression of both genes simultaneously (Shu et al., 
2006). This may also be the case for nephrin and Neph3 genes. Since specific regions of 
DNA methylation in nephrin and Neph3 sequence were not clarified, it is also possible that 
the effect of demethylating agent is indirect and modulates the expression of the 
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transcription factors or the other components of the signalling pathways (Karpf and Jones, 
2002; Schmelz et al., 2005). 
The mechanism of how methylation affects gene expression may be reduced accessibility 
of transcription factors to the methylated promoter (Watt and Molloy, 1988; Tate and Bird, 
1993). However, demethylation is not always a prerequisite for the binding of the 
transcription factor; sometimes demethylation follows the binding of the transcription 
factor. Of the known nephrin and Neph3 gene regulators, Sp1 is linked to the maintenance 
of the methylation-free status of the CpG island (Brandeis et al., 1994; Macleod et al., 
1994), and, interestingly, a functional Sp1 binding site in the Neph3 promoter is located on 
the CpG island (Study II). NF-?B is also suggested to play a role in protecting DNA from 
methylation (Kirillov et al., 1996), and similarly to Sp1, its binding site in the Neph3 
promoter is present on the CpG island (Study II). Since the precise location of functional 
binding site(s) for NF-?B in the nephrin promoter has not been determined, it remains 
unclear whether they occupy a CpG island. It is possible, however, that Sp1 and NF-?B can 
co-operate with DNA methylation in the regulation of nephrin and Neph3 genes. 
5.4 GABP regulates nephrin gene 
GA-binding protein (GABP) (also known as adenovirus E4 transcription factor [E4TF-1] or 
nuclear respiratory factor 2 [Nrf-2]) belongs to the Ets family of transcription factors. It is a 
heterotetramer composed of two subunits, GABP? and GABP?, both of which are needed 
to generate a functional complex (Sawa et al., 1996). GABP? contains an Ets DNA-binding 
domain that binds to DNA sequences rich in the nucleotides guanine and adenine. GABP? 
harbours a nuclear localization signal and also ankyrin repeats, which mediate the 
dimerization to ?-subunit (reviewed by Rosmarin et al., 2004). Mammalian GABP is 
ubiquitously expressed and has also been shown to be distributed in adult mouse kidney at 
the mRNA level (O'Leary et al., 2005). Study IV demonstrated that GABP is expressed in 
glomeruli and localizes in podocyte nuclei and also in nuclei of other cell types in the 
glomerulus. 
5.4.1 GABP and cell adhesion 
GABP is essential for early embryogenesis, as deletion of GABP? in mice results in 
embryonic lethality (Ristevski et al., 2004). GABP is implicated in several critical cellular 
processes, including cell growth, cellular respiration, ribosome synthesis, differentiation 
and cell cycle. Despite GABP being expressed in a wide variety of tissues and controlling 
the expression of housekeeping genes, GABP also targets many lineage-restricted genes 
(reviewed by Rosmarin et al., 2004). Interestingly, GABP regulates the expression of ?4-
integrin gene, whose protein product is involved in mediating cell-cell and cell-matrix 
interactions in leukocytes (Rosen et al., 1994). GABP is also suggested to be essential in 
regulating myeloid cell adhesion to the endothelium by targeting several key myeloid genes 
(Bottinger et al., 1994; Rosen et al., 1994; Nickel et al., 1995; Rosmarin et al., 1995; 
Nuchprayoon et al., 1997), and further, GABP is linked to the formation and function of 
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neuromuscular junctions by regulating the expression of synaptic genes (Fromm and 
Burden, 1998; Khurana et al., 1999; Mejat et al., 2003). One of these synaptic genes is 
utrophin, which is also expressed in podocytes. Utrophin localizes in the cytoplasm of the 
foot processes and is involved in linking the podocyte cytoskeleton to the glomerular 
basement membrane (Raats et al., 2000). Study IV revealed that GABP participates in the 
regulation of the nephrin gene in podocytes (Figure 18). As nephrin is a component of the 
SD junction (Holthöfer et al., 1999; Holzman et al., 1999; Ruotsalainen et al., 1999) and 
existing data (Liu et al., 2003; Gerke et al., 2005; Nishida et al., 2010) and Study I 
demonstrate that nephrin has a role in cell adhesion, it is tempting to speculate that GABP 
may have an important role in the formation or maintenance of the SD by regulating the 
expression of the nephrin gene and possibly also other podocyte genes. 
5.4.2 Combinatorial activity of GABP and other transcription factors 
GABP is often found in large complexes with other transcription factors, and it appears that 
the physical and functional interactions between GABP and other transcription factors and 
co-activators play a key role in regulating the expression of lineage-restricted genes 
(reviewed by Rosmarin et al., 2004). Thus, the regulation of nephrin gene transcription by 
GABP is most probably influenced by other transcription factors. Of the known nephrin 
gene regulators, Sp1 is reported to co-operatively activate transcription of several types of 
genes together with GABP (Rosmarin et al., 1998; Shirasaki et al., 1999; Gyrd-Hansen et 
al., 2002; Jiang et al., 2002; Rudge and Johnson, 2002; Takahashi et al., 2008). Further, co-
operative interactions between RAR, GABP and Sp1 are proposed to be required for 
transcriptional activation of the CD18 gene by retinoic acid in myeloid cells (Bush et al., 
2003). Whether co-operativity between GABP and Sp1 is important in nephrin gene 
regulation or interaction between RAR, GABP and Sp1 is involved in retinoic acid-induced 
transcription of the nephrin gene remains to be clarified. 
5.4.3 Other features of GABP as a transcriptional regulator 
Several interesting features have been linked to GABP. First, GABP binding site has been 
shown to be overrepresented in promoters of head-to-head oriented genes and to mediate 
bidirectional transcriptional activity. For this, co-operative binding of multiple transcription 
factors has been proposed (Collins et al., 2007; Lin et al., 2007; Huang and Chang, 2009). 
Since nephrin and Neph3 genes form a bidirectional gene pair, we investigated the effect of 
GABP also on Neph3 regulation, but GABP overexpression activated neither the Neph3 
promoter  in  a  reporter  gene  assay  nor  the  endogenous  Neph3  mRNA  measured  by  
quantitative PCR (unpublished data). It may be, however, that GABP participates in Neph3 
gene regulation, not necessarily by itself, but by co-operating with other transcription 
factors involved in the regulation of the nephrin and/or Neph3 gene, such as WT1, NF-?B 
and Sp1. A second interesting feature of GABP is its methylation-sensitive character. 
GABP  has  been  shown  to  be  recruited  to  the  DNA  when  the  locus  is  unmethylated  
(Yokomori et al., 1995; Lucas et al., 2009). Study III demonstrated that DNA methylation 
plays a role in silencing nephrin expression, and thus, methylation may contribute to in 
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GABP-mediated nephrin gene regulation. Lastly, in addition to being a transcriptional 
activator, GABP has been shown to function also as an initiator factor for genes with a 
TATA-less promoter (Yu et al., 1997). Nephrin does not have a TATA box and GABP 
binding sites in the nephrin promoter are located very near the TSS (Study IV), and thus, 
GABP-directed transcription initiation might be involved in regulation of the nephrin gene. 
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6 CONCLUSIONS AND FUTURE PERSPECTIVES 
 
Nephrin  is  a  structural  backbone  and  signalling  protein  of  the  SD  that  is  crucial  in  the  
maintenance of glomerular filtration barrier permselectivity. Nephrin homologues Neph1-3, 
comprising the Neph-protein family, are also components of the SD and participate in 
glomerular filtration. It is thus important to understand how these molecules participate in 
the formation of the SD and how they are structurally and functionally regulated. This work 
revealed that nephrin and Neph3 have similar functions by sharing similar binding 
properties and participating in cell adhesion. Further, nephrin and Neph3 genes were shown 
to share similar transcriptional regulatory mechanisms. 
The data in this thesis show that Neph3 belongs to the nephrin protein complex and forms 
homodimers. The results also provide novel information about the function of nephrin, 
Neph1 and Neph3 in the formation of cell-cell contacts, indicating that Neph1 and Neph3 
are homophilic adhesion molecules. Heterophilic trans-interactions between nephrin and 
Neph1 or Neph3 also promoted cell adhesion and induced de-phosphorylation of nephrin. 
These results suggest that Neph3 shares similar functions with nephrin and Neph-family 
members and may participate together with them in the formation and function of the SD. 
Neph3 was found to be up-regulated in the kidneys of nephrin-deficient mice with podocyte 
foot process effacement and displacement of the SDs with tight junction-like structures. 
Further investigations are needed to identify the molecular pathways and mechanisms 
associated with nephrin and Neph1/Neph3 interactions to induce cell adhesion and that lead 
to morphological changes in podocytes of nephrin-deficient kidneys. Specific kinases and 
phosphatases involved in regulating nephrin phosphorylation upon cell adhesion also 
remain to be identified. Further, to confirm the role of Neph3 in the formation and function 
of the SD, a podocyte-specific Neph3 knock-out mouse should be produced. 
Glomerular transcription factors have been invesigated extensively, but fewer studies have, 
however, concentrated on elucidating the transcriptional regulatory mechanisms of 
podocyte molecules, including nephrin and Neph3 genes. This work provides novel 
discoveries in the transcriptional regulation of the constitutive expression of human nephrin 
and Neph3 genes. Based on the bidirectional arrangement of nephrin and Neph3 genes and 
the similar structure and location of their protein products, nephrin and Neph3 genes have 
been proposed to share key features in their regulation. In the developing central nervous 
system of the mouse, both nephrin and Neph3 genes have been shown to be regulated by 
transcription factor Ptf1a (Nishida et al., 2010). The results of this thesis provide the first 
evidence that nephrin and Neph3 genes are regulated by common mechanisms also in 
podocytes. Transcription factors WT1 and NF-?B were shown to participate in the 
regulation of nephrin and Neph3 genes co-operatively. In addition, DNA methylation 
played a similar role in silencing nephrin and Neph3 gene expression. Neph3 gene was 
further shown to be regulated by Sp1 and the nephrin gene by GABP. Nephrin and Neph3 
genes are most probably regulated by several factors acting together to produce their exact 
cell and developmental stage-specific expression. It is important to pursue investigating 
these mechanisms in-depth to clarify how they affect the function of nephrin and Neph3 in 
the SD in the basal state, during development and during progression of glomerular 
diseases. For example, it would be interesting to clarify whether similar mechanisms in the 
transcriptional regulation of nephrin and Neph3 genes regulate the similar functions of their 
protein products. 
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Understanding how transcription of nephrin and Neph3 genes is regulated may also shed 
light on transcriptional regulation in podocytes in general and provide novel insights into 
the differentiation and function of podocytes. One important question remains to be 
answered – are there similar regulatory mechanisms also for other podocyte genes? 
Transcription factors WT1 and Sp1 have been shown to regulate podocalyxin (Palmer et al., 
2001; Butta et al., 2006). Sp1 also regulates CD2AP (Lu et al., 2008; Su et al., 2009). 
Further, DNA methylation plays a role in the cell type-specific expression of podocalyxin 
(Butta et al., 2006). Studies with renal biopsies from patients with acquired human 
glomerular diseases show correlations in the mRNA expression of nephrin and Neph3 as 
well as in the mRNA expression of other genes expressed in podocytes, suggesting that 
common regulatory mechanisms may be activated in proteinuric glomerular diseases 
(Schmid et al., 2003; Ihalmo et al., 2007). However, the transcriptional regulatory 
mechanisms that lead to these down-regulations remain to be elucidated. Mutations in the 
intergenic region of nephrin and Neph3 genes found in CNF patients are not located in the 
regions that we focused on in this thesis, but it would be of interest to determine whether 
these mutations affect the expression of nephrin and Neph3 genes by disrupting the binding 
of some other crititical transcription factors.  
In conclusion, this work has extended current knowledge of nephrin and Neph3, revealing 
that they have similar functions and that the transcription of their genes is regulated by 
similar mechanisms. Nephrin and Neph3 were shown to play a role in cell adhesion, which 
may be important in the formation of the SD. Further, novel transcriptional regulatory 
mechanisms for nephrin and Neph3 genes were identified. This may shed light on the 
transcriptional regulatory processes in podocytes in general and provide novel insights into 
the function of podocytes.  
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